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ROLE OF MITOCHONDRIAL BETA-OXIDATION IN ETHANOL 
RESPONSE: A CANDIDATE GENE STUDY USING CAENORHABDITIS 
ELEGANS 
 
By Harini Pallikarana Tirumala 
Master of Science in DNA Profiling from University of Central Lancashire, UK 
2012 
Directed by Jill C. Bettinger, Ph.D., Professor of Pharmacology and 
Toxicology 
 
Virginia Commonwealth University, 2017  
 
Alcohol use disorder (AUD) is the fourth leading cause of preventable death in 
the United States, and the fifth leading risk factor for premature death and 
disability, globally. There are currently very few treatment options for AUD and 
there is a need for effective preventive and treatment strategies for this 
condition. AUD risk has a significant hereditary component, with the 
contribution of genetic factors being estimated to be about 50%. The Davies-
Bettinger laboratory uses C. elegans as a model organism to study the 
contribution of genetic factors in modulating neuronal responses to ethanol. In 
this project, we examined the role of mitochondrial beta-oxidation of fatty 
acids (FA) in altering ethanol responses using loss-of-function (lf) mutants and 
RNAi-mediated knockdown of specific genes in this pathway. We tested a 
total of 34 genes and found that lf in 13 genes significantly affected ethanol 
response phenotypes.  We conclude that mitochondrial beta-oxidation of FA is 
essential for ethanol response behavior in C. elegans. Further experiments 
need to be conducted to dissect the specific contribution of various 
components of mitochondrial beta-oxidation in modifying the neuronal 
responses to ethanol.  
 1 
 
1. INTRODUCTION 
 
1.1. Alcoholism – National and Global Impact 
“First you take a drink, then the drink takes a drink, then the drink takes you.” 
~ F. Scott Fitzgerald  
Alcohol is ranked among the top ten most addictive substances in the world 
(Nutt et al., 2007). The National Institute on Alcohol Abuse and Alcoholism 
(NIAAA) defines AUD as ‘problem drinking that becomes severe’. Medical 
diagnosis of AUD requires an individual to meet at least 2 out of the 11 criteria 
outlined in the Diagnostic and Statistical Manual of Mental Disorders (DSM), 
within the same 12-month period. AUD can be classified as mild, moderate or 
severe based on the number of criteria fulfilled. 
 
According to the 2015 National Survey on Drug Use and Health (NSDUH), 
15.1 million adults (18 years and older) in the United States had AUD and the 
financial burden due to alcohol misuse in the US in 2010 was $249 billion. 
While it is estimated that alcohol claims about 88,000 lives every year in the 
US, in 2014 alone, alcohol-impaired driving fatalities accounted for 31% of 
overall driving fatalities. With such a profound and significant impact on the 
mortality and economy of the country, alcohol is the fourth leading 
preventable cause of death in the United States. Statistics around the world 
reflect a similar scenario with alcohol misuse being ranked as the fifth leading 
risk factor for premature death and disability, globally (Alcohol facts and 
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statistics, 2017). Specifically, about 25% of total deaths in the 20-39 years 
age group are alcohol-attributable (WHO alcohol fact sheet, 2015). 
 
Given the huge impact of alcohol abuse on individual and public health, global 
economy and productivity, there is a need for effective prognostic, preventive 
and therapeutic strategies to treat AUD. At present, the treatment for AUD is 
largely focused on therapeutic counseling and other forms of behavioral 
therapy. There are currently only three FDA approved drugs for treating 
individuals suffering from AUD: Disulfiram, Naltrexone and Acamprosate 
(Krishnan-Sarin et al., 2008). It is therefore important to invest in alcohol 
research to identify effective prevention, management and treatment options 
to curb the increasing rate of mortality associated with this debilitating 
condition. 
 
1.2. Genetics of alcoholism 
AUD is a multifactorial condition influenced by both environmental and genetic 
factors, like most psychiatric and behavioral disorders. The contribution of 
genetic factors to AUD risk has been estimated, by numerous family and twin 
studies, to be in the range of 40-60% (Palmer et al., 2012), with the most 
recent best-fit estimate being 49% (Verhulst et al., 2015). This is supported by 
a multitude of molecular genetic studies that have identified several genetic 
variants in candidate genes, which significantly influence the risk of 
developing AUD. However, all of these variants put together only account for 
a very small percentage of the genetic variance determined by the family 
studies. Thus it is clear that there are multiple genes and genetic interactions 
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that affect risk for AUD. This makes it a complex genetic condition to study, 
even without taking into consideration the role of social and environmental 
factors (Edenberg & Foroud, 2013). 
 
Among the various negative effects of alcohol on human health, two of the 
major areas of AUD research are physiological effects of alcohol metabolism 
and the (direct) effects of alcohol on the brain and nervous system. Alcohol 
dehydrogenase subunit beta (ADH1B) and aldehyde dehydrogenase 2 
(ALDH2) are two enzymes are involved in ethanol metabolism. ADH1B 
catalyzes the conversion of ethanol to acetaldehyde and the mitochondrial 
ALDH2 is involved in the second step of this metabolism converting 
acetaldehyde to acetate. Among genes that catalyze alcohol metabolism 
(primarily in the liver), variants in ADH1B and ALDH2 are the most 
significantly associated with risk of AUD (Tawa et al., 2016). Reactions 
catalyzed by both these genes utilize NAD+ to produce NADH, altering the 
NADH/NAD+ ratio within the cell. This increased NADH/NAD+ ratio inhibits 
mitochondrial beta-oxidation of FA, as it is an allosteric regulator of this 
pathway. Most of the acetate produced from the second reaction enters the 
circulation and is metabolized to CO2 in heart, brain and skeletal muscle cells. 
Acetate is also metabolized to acetyl CoA, which then enters metabolic 
pathways such as ketone body production, amino acid and FA synthesis. 
Acetate produced from acetaldehyde also enters the brain. Though the brain 
primarily derives its energy from oxidation of glucose, the availability of 
acetate, which requires fewer steps for oxidation and energy production, 
 4 
results in increased acetate uptake and decreased glucose utilization in the 
brain. 
 
Alcohol also exerts a wide range of effects on the central nervous system 
(CNS) which can cause effects that include an increase in aggression, 
reduced inhibition and impaired memory as it affects multiple pathways and 
regions in the brain (M. Davies, 2003). The most prominent among these are 
neurotransmitter-signaling pathways that affect the inhibitory and excitatory 
systems in the brain (McIntosh & Chick, 2004). Genes in various 
neurotransmitter-signaling pathways (particularly receptors) have been 
implicated in AUD risk development. Some of the most widely researched 
ones in this group include the γ-Aminobutyric acid (GABA) receptors, genes in 
the serotonin, dopamine and glutamate pathways like the serotonin-
transporter-linked polymorphic region (5’-HTTLPR), dopamine receptor D2 
(DRD2) (Banerjee, 2014) and glutamate metabotropic receptor 8 (GRM8) 
respectively (Morozova et al., 2014). Despite extensive research, little is 
known about the exact mechanisms of alcohol’s action on the nervous 
system. 
 
1.3. Neuronal response to alcohol 
AUD is a heterogeneous condition with a spectrum of clinical manifestations, 
and several alcoholism typologies have been proposed to group together 
affected individuals with a similar clinical course, in order to better predict their 
response to treatment (Bogenschutz et al., 2009). Identifying genetic factors 
associated with the condition is complex, probably due to this heterogeneous 
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nature of AUD and the symptom-based diagnosis used (DSM criteria). 
Therefore, scientists identified certain endophenotypes that can be used as 
biomarkers and can be linked to specific genetic factors that could play a role 
in development of AUD (Gottesman & Shields, 1973). An endophenotype is 
any trait that is related to or part of a condition and might be influenced by a 
small number of genes. It can be used to bridge the gap between biology of 
the condition and its symptoms. In psychiatry research, a biomarker has to 
fulfill the following criteria to be considered an endophenotype: it must 
segregate with illness in the population and within families, must be heritable, 
must not be state-dependent, must be present at a higher rate within affected 
families than in the population, must be reliably measurable and specific to 
the illness.  
 
There are several established endophenotypes of AUD (Eng et al., 2005; 
Salvatore et al., 2015). Level of response to alcohol is a reproducible and 
well-characterized endophenotype, and it is commonly used in animal models 
of alcohol research. Level of response can be defined as the ‘intensity of 
response to alcohol at a specific Blood Alcohol Concentration (BAC)’ 
(Schuckit et al., 2011). It has been consistently shown that low level of 
response (LR) to alcohol is a strong predictor of increased risk for AUD in the 
future and that it is to an extent genetically influenced (Schuckit, 1980; 
Schuckit, 1994). LR constitutes at least two components that are routinely 
used in the lab, namely initial sensitivity (which refers to the level of 
intoxication that appears soon after ethanol administration, when blood 
ethanol levels are rising) and acute functional tolerance (AFT, the 
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tolerance/adaptation of brain function developed within a single drinking 
session, recorded at an equivalent concentration of alcohol on the declining 
phase BAC relative to the rising phase BAC at initial sensitivity). These two 
components have been successfully used to study the impact of genetic 
factors on AUD in various invertebrate and vertebrate models (Engleman et 
al., 2016; Morozova et al., 2014; Ponomarev & Crabbe, 2002).  
 
1.3.1. Using C. elegans to study the molecular basis of neuronal response to 
alcohol 
Caenorhabditis elegans is a soil-dwelling, free-living nematode that has been 
used as a model for research since early 1960s. Being the first multicellular 
organism whose whole genome was sequenced, C. elegans is currently being 
extensively used in research areas such as neuronal development, molecular 
biology, genetics and developmental biology. Features like the ability to self-
fertilize (hermaphrodites) and mate with males, large brood size, short life 
cycle, relatively small genome size (100.2Mb) and ease of genetic 
manipulation (mutagenesis, RNA interference) make it an ideal model 
organism for genetic studies. The primary reason for using C. elegans in 
neuronal research is that its nervous system is simple but one of the most 
extensively characterized among multicellular organisms, with a total of 302 
neurons (in the adult hermaphrodite). Despite its small size, the C. elegans 
nervous system is complex and shares most of the mammalian 
neurotransmitters, receptors and their molecular components. Among them 
are serotonin, GABA, glutamate, dopamine and acetylcholine. Also, the basic 
structural organization of neuron subtypes into sensory neurons, interneurons, 
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and motor neurons is conserved between humans and C. elegans. The entire 
wiring of neural circuits or the connectome of C. elegans was mapped by 
John G. White in 1986, and this opened up the possibility of identifying the 
functions of each individual neuron and its contribution to the nervous system. 
C. elegans also exhibits complex behavioral traits (like chemo- and 
mechanosensation, thermotaxis and avoidance of noxious stimuli) and 
behavioral plasticity which makes it a useful model for neurobiology (Hobert, 
2003).  
 
Most behavioral studies in C. elegans utilize the change in locomotion pattern 
in response to stimuli, as a measurable phenotype. Worms move by 
undulatory propulsion; waves formed by the contraction and relaxation of 
dorsal and ventral longitudinal body muscles travel along the length of the 
body and allow forward propulsion (de Bono & Maricq, 2005). Motor behavior 
is a trait that is predominantly under the control of the nervous system. 
Therefore, effects on the nervous system are often displayed through 
changes in motor behavior.  
 
Neuronal responses to alcohol appear to be conserved in some invertebrates 
including C. elegans (McIntire, 2005). Moreover, the intoxicating effects of 
ethanol in C. elegans occur at similar concentrations as in mammals, which 
make it an excellent model to study the effect of alcohol on the nervous 
system. Behavioral responses to ethanol in humans include loss of social 
inhibition and lack of coordination. Acute exogenous exposure to ethanol also 
results in behavioral changes in C. elegans and these effects were found to 
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be dose-dependent and reversible (A. Davies et al., 2003a). One such 
behavioral response to alcohol in C. elegans is the development of acute 
tolerance, a component of level of response. As is observed in vertebrate 
systems (Crabbe et al., 2013; Erwin et al., 2000; LeBlanc et al., 1975; 
Ritzmann & Tabakoff, 1976), including humans (Hiltunena et al., 2000; Kaplan 
et al., 1985), the level of response to ethanol in C. elegans involves 
development of AFT shortly after ethanol administration (A. Davies et al., 
2004). 
 
To dissect the genetic contribution to ethanol response behavior, which 
reflects risk for AUD, researchers have exploited this conserved behavioral 
effect in C. elegans. A. Davies et al., (2003b) conducted genetic screens to 
identify mutants with reduced sensitivity to ethanol and observed that 
exogenously applied ethanol modifies locomotion and egg-laying behavior in 
C. elegans. Exposing the worms to short continuous doses of ethanol, they 
saw that it produced reversible and dose-dependent decrease in speed of 
locomotion and amplitude of body bends during locomotion. Level of response 
to alcohol in C. elegans is typically measured by change in locomotion speed 
of the worms at different time points after acute exposure to ethanol. There is 
an initial depression in locomotion speed that is accompanied by fewer body 
bends (initial sensitivity) immediately after exposure. The speed of locomotion 
increases over the time course of the assay, despite constant (or in some 
instances, increased) internal concentration of ethanol, which supports 
previous findings that this increase in speed over time is due to a neuronal 
adaptation to the physiological effects of ethanol and not due to decrease in 
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the internal ethanol concentration (Davies et al., 2004). This increase in 
locomotion speed after the initial depression is termed AFT. It is important to 
note that these two components of LR, initial sensitivity and AFT have been 
found to be genetically separable (A. Davies et al., 2015). 
 
1.4. Background research for current project 
The Davies-Bettinger lab has identified several genes that modulate neuronal 
responses to ethanol in C. elegans including a calcium-activated potassium 
channel, Slowpoke protein 1 (slo-1) (A. Davies et al., 2003b), eat-6 which 
encodes the alpha-subunit of the Na+/K+ ATPase (Hawkins et al., 2015), a 
neuropeptide Y (NPY) receptor-like protein (npr-1) (A. Davies et al., 2004) and 
a Ras-family GTPase (rab-3) (Kapfhamer et al., 2008). An area of interest to 
the lab is the role of the lipid environment in modulation of ethanol responses. 
Using an unbiased genetic screen, they determined that lips-7 and ctbp-1 (C-
terminal binding protein 1), a transcriptional regulator of lips-7 affect AFT to 
ethanol. In another study looking at the role of ctbp-1 on lifespan in C. 
elegans, Chen et al., (2008) observed that ctbp-1 mutants had altered 
triacylglycerol (TAG) levels. Since TAGs are components of the lipid 
membrane, Bettinger et al., (2012) tested the effect of lipid membrane 
environment on AFT by depleting cholesterol, another important component of 
the lipid membrane, in the media on which worms are grown. They observed 
that worms grown on cholesterol-depleted media displayed suppression of 
AFT development, which suggested that the composition and structure of the 
lipid membrane is important for normal development of AFT. 
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Additional studies in the lab, examining another component of the lipid 
environment, have shown that eicasapentanoic acid (EPA), an omega-3 long-
chain polyunsaturated fatty acid (LC-PUFA), is required for development of 
AFT in C. elegans and dietary supplementation of EPA restored WT AFT in 
EPA-deficient mutants. Also, supplementation of EPA enhanced AFT 
significantly in N2 worms while the basal speeds remained unchanged 
implying that LC-PUFAs have an important role in regulating response to 
ethanol (Raabe et al., 2014).  
 
In an effort to identify genes involved in the modulation of ethanol responses 
in C. elegans, Dr. Joseph Alaimo, a former student in the lab, performed a 
microarray analysis of ethanol responsive genes in two strains of C. elegans: 
N2 (wildtype, WT) and npr-1(ky13) which is a lf mutation (a C-to-T transition 
that introduces a stop codon) that shows significantly higher AFT compared to 
N2 (Alaimo, 2013). The npr-1(ky13) strain was chosen due to its marked 
increased tolerance to ethanol compared to the WT worms. Comparing the 
gene expression profiles between these two strains could potentially reveal 
genes that contribute to the increased AFT phenotype seen in npr-1(ky13). 
These differentially expressed genes would make excellent candidates for 
further research for a role in ethanol responses. Dr. Alaimo compared gene 
expression differences between untreated (basal) and acute ethanol treated 
N2 (WT) worms and npr-1(ky13) mutant worms and generated three 
expression profiles: npr-1(ky13) basal (the set of genes differentially 
expressed between the untreated npr-1(ky13) and N2 worms), N2 ethanol 
(the set of genes differentially expressed between the ethanol-treated N2 
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worms and untreated N2 worms) and npr-1(ky13) ethanol (the set of genes 
differentially expressed between the untreated npr-1(ky13) and ethanol-
treated npr-1(ky13) worms).  
 
He looked at the intersection of these three expression profiles (i.e., genes 
common across the three groups) and found that 20 genes were differentially 
expressed in all three profiles, which suggested that these are top candidate 
genes in modulating the ethanol response phenotypes (as these are 
differentially expressed at the basal level in npr-1(ky13) and also are ethanol 
responsive). Out of these 20 genes, based on a ranking system that 
considered allele availability, known phenotypes reported on WormBase 
(http://www.wormbase.org), neuronal expression and presence of mammalian 
homologs, Dr. Alaimo selected acs-2 (acyl-CoA synthase 2) for behavioral 
testing and he observed that acs-2(lf) mutants showed significantly reduced 
development of AFT compared to N2 (Figure 1A). He then performed an 
experiment to determine if the alteration in ethanol response in the acs-2 
mutants was due to increased ethanol entry or change in internal ethanol 
concentration. He showed that neither of these two phenomena was 
responsible for the reduced AFT observed (Figure 1B). This implied that the 
difference in behavioral responses to ethanol could be due to physiological 
differences in the effects of ethanol in these mutants.  
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Figure 1. acs-2 modifies AFT and does not alter ethanol metabolism (A) At 400mM 
exogenous ethanol, acs-2(ok2457) display a similar initial sensitivity to N2, but develop 
significantly less AFT. acs-2(ok2457);npr-1(ky13) animals also have a similar initial sensitivity 
relative to npr-1(ky13) and acs-2(ok2457), but have a reduced AFT that is significantly 
different than npr-1(ky13), but not acs-2(ok23457) or N2. (n = 9)(B). Internal ethanol 
concentrations are similar across all mutants suggesting the observed behavioral effects are 
not due to ethanol metabolism. (n = 4). Error bars are SEM.  * P < 0.5 , ** P < 0.01, *** P < 
0.001. Reprinted with permission from “Identification and Characterization of Ethanol 
Responsive Genes in Acute Ethanol Behaviors in Caenorhabditis elegans”, unpublished 
thesis, by J. Alaimo, 2013. 
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acs-2 is a gene involved in the first step of mitochondrial beta-oxidation, it 
codes for acyl-CoA synthase (ACS) which catalyzes the activation of FA to 
fatty acyl CoA (to facilitate entry into the mitochondria) (Van Gilst et al., 
2005a). Lf mutants of acs-2 exhibit accumulation of fat since there is a 
disruption of FA activation (Zhang et al., 2011). Dr. Alaimo conducted further 
behavioral assays by attempting to knockdown specific genes at different 
steps in mitochondrial beta-oxidation (cpt-2, cpt-5, ech-1, ech-2, ech-4, ech-6, 
T08B2.7) using RNA interference. These studies revealed that only 
knockdown of ech-6 by RNAi altered AFT resulting in enhanced AFT 
compared to the control (L4440) (Figure 2), while none of the other RNAi 
experiments showed a significantly different ethanol response phenotype from 
the control, L4440. This could have been due to inefficient knockdown of 
genes by RNAi, so it does not rule out these genes as candidates. Therefore, 
these experiments suggested a role for mitochondrial beta-oxidation in 
regulating the ethanol response behavior in C. elegans. Treating this as 
preliminary evidence, we designed the current project to answer the following 
question: Do genes involved in mitochondrial beta-oxidation of FA play a 
role in modulating ethanol response in C. elegans? 
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Figure 2. Mitochondrial β-oxidation may influence acute ethanol behaviors. (A) At 
400mM exogenous ethanol cpt-2(RNAi) and cpt-5(RNAi)  animals displayed similar initial 
sensitivity and development of AFT relative to control (n = 4). (B) ech-2(RNAi), ech-4(RNAi), 
and ech-1(RNAi) mutant animals also display similar initial sensitivity and AFT relative to 
control (n = 4). (C) T08B2.7 (RNAi) animals were not different than control for initial sensitivity 
or AFT. ech-6(RNAi) mutants displayed an enhanced AFT relative to WT, but initial sensitivity 
was not significantly different (n = 8). Error bars represent SEM * P < 0.05, ** P < 0.01, ***P < 
0.001. Reprinted with permission from “Identification and Characterization of Ethanol 
Responsive Genes in Acute Ethanol Behaviors in Caenorhabditis elegans”, unpublished 
thesis, by J. Alaimo, 2013. 
L4440 ech-2 ech-4 ech-1
10’ 30’ 10’ 30’ 10’ 30’ 10’ 30’
A
FT(10-30’)
%
 recoveryS
pe
ed
 
(%
 o
f u
nt
re
at
ed
)
**
* * *
L4
44
0
ec
h-2
(R
NA
i)
ec
h-4
(R
NA
i)
ec
h-1
(R
NA
i)
0
20
40
60
0
5
10
15
n.s.
 S
pe
ed
 
(%
 o
f u
nt
re
at
ed
) A
FT (10-30’)
%
 recovery
10’ 30’ 10’ 30’ 10’ 30’
L4440 ech-6 T08B2.7
L4
44
0
ec
h-6
(R
NA
i)
T0
8B
2.7
(R
NA
i)
0
20
40
60
80
0
5
10
15
20
25
***
***
**
**
n.s.
L4
44
0
cp
t-2
(R
NA
i)
cp
t-5
(R
NA
i)
0
20
40
60
80
0
5
10
15
20
A
FT (10-30’)
%
 recovery 
S
pe
ed
 
(%
 o
f u
nt
re
at
ed
)
10’ 30’ 10’ 30’ 10’ 30’
L4440 cpt-2 cpt-5
*
*
n.s.A
B
C
 15 
 
1.5. Mitochondrial Beta-Oxidation 
The first step in understanding the role of mitochondrial beta-oxidation genes 
in ethanol response was to characterize and annotate the mitochondrial beta-
oxidation pathway. FA are a major energy source in multicellular organisms 
as they yield large quantities of ATP upon degradation and are also required 
for formation of various macromolecules.  FA oxidation is an important 
metabolic process that maintains energy homeostasis, particularly under 
reduced glucose availability when FA act as the primary source of energy that 
can be directly used by most tissues, except the brain. FA are also converted 
to ketone bodies which serve as alternate energy sources for all tissues 
including the brain (Houten et al., 2010).  
 
Mitochondrial beta-oxidation is the primary pathway of FA degradation and, as 
the name implies, it occurs in the mitochondria of eukaryotic cells (Kunau et 
al., 1995). Beta-oxidation also occurs in peroxisomes in some higher 
eukaryotic organisms, but a major difference between mitochondrial and 
peroxisomal beta-oxidation is that peroxisomes typically oxidizes very-long-
chain FAs (> C22), pristanic acid, and the bile acid intermediates di- and 
trihydroxycholestanoic acid, while mitochondria are the site of oxidation for all 
other FA species. Also, FAs oxidized in the peroxisomes have to further 
undergo complete oxidation in the mitochondria (Wanders & Waterham, 
2006). Beta-oxidation in the mitochondria occurs through the following steps 
(see Figure 3): (1) Activation: In the cytosol, FA are activated by the addition 
of CoA to form acyl CoA, and this is catalyzed by ACS in a two-step process. 
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FA reacts with ATP to give fatty acyl adenylate (an intermediate compound) 
and inorganic pyrophosphate in the first step, which then react with coenzyme 
A (CoA) to form acyl CoA and AMP (2) Transport: Long-chain acyl CoA esters 
are transported across the mitochondrial membrane into the matrix for 
oxidation by carnitine palmitoyl transferases (CPT) (short and medium chain 
acyl CoA esters are activated in the matrix and do not need carnitine shuttle 
for transport across the membrane). (3) Dehydrogenation (first): Acyl CoA 
dehydrogenases (ACAD/ACDH) catalyze the conversion of acyl CoA to trans-
2-enoyl CoA. This creation of a trans double bond between C2 and C3 
requires FAD+ as electron acceptor that is reduced to FADH2. (4) Hydration: 
Trans-2-enoyl CoA is converted to 3-hydroxy acyl CoA by enoyl CoA 
hydratase (ECH) enzymes. (5) Dehydrogenation (second): In the second 
dehydrogenation, 3-hydroxy acyl CoA is catalyzed by 3-hydroxy acyl CoA 
dehydrogenase (HADH/HACD) to form 3-keto acyl CoA, using NAD+ as the 
electron acceptor which gets reduced to NADH. (6) Thiolytic cleavage: In the 
final step, 3-keto acyl CoA thiolase (KAT) cleaves keto acyl CoA to produce 
acetyl CoA and a fatty acyl CoA that is shortened by two carbons which goes 
through the same cycle again until it is completely oxidized (Wanders et al., 
2010). Acetyl CoA enters the citric acid cycle to produce carbon dioxide (CO2) 
and water (H2O). The NADH and FADH2 produced in beta-oxidation and citric 
acid cycle are utilized in the electron transport chain (ETC). The total energy 
yield from each cycle of oxidation is 14 ATP (acetyl CoA enters the citric acid 
cycle and yields 10 ATP, NADH and FADH2 enter the ETC and produce 2.5 
ATP and 1.5 ATP respectively).  
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Figure 3. Mitochondrial beta-oxidation of FA. Reaction steps, enzymes and energy 
transfers involved in mitochondrial beta-oxidation of FA. Numbers within boxes at each step 
of the pathway correspond to enzymes listed in the top right corner of the figure.  
 
1.5.1. Mitochondrial beta-oxidation in C. elegans 
C. elegans is increasingly being utilized to model mammalian metabolic 
pathways and associated disorders as a majority of physiological processes 
appear to be conserved in these nematodes (Mullaney & Ashrafi, 2010). 
Looking specifically at mitochondrial beta-oxidation of FA, the general steps of 
the pathway appear to be conserved between mammals and C. elegans 
(Table 1). Though conserved in primary function, there is evolutionary 
divergence in terms of protein sequence between the mammalian and 
C. elegans beta-oxidation enzymes. Other aspects such as substrate 
specificity, expression pattern, subcellular localization and auxillary functions 
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have not yet been extensively studied in C. elegans to determine the extent of 
similarity to their human homologs/orthologs.  
 
Mitochondrial beta-oxidation has not been very well characterized in 
C. elegans (Li et al., 2010). There are a significant number of studies 
exploring the role of mitochondrial dysfunction in the context of oxidative 
stress relating to various metabolic (Lowell & Shulman, 2005) and 
neurodegenerative diseases (Ray et al., 2014), lifespan and aging (Dai et al., 
2014). However, only a small number of studies have looked at beta-oxidation 
of FA in particular, and these studies focused on subsets of genes mostly with 
relevance to transcriptional regulators mediating nutrient response and fat 
metabolism (Xu et al., 2015; Van Gilst et al., 2005a; Van Gilst et al., 2005) 
and none of these (published to date) have elucidated or comprehensively 
reviewed the mechanism of mitochondrial FA beta-oxidation in C. elegans. 
 
A brief overview of each family of genes encoding the enzymes at each step 
of beta-oxidation in humans and C. elegans based on published literature is 
presented here to give the necessary background to appreciate the wide 
range of effects of these genes on ethanol response behavior in C. elegans 
which will be discussed in the Results and Discussion section. 
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Table 1. Step-by-step comparison of mitochondrial beta-oxidation in humans and C. elegans 
Reaction Enzyme (Human) Genes (Human) Enzyme(C. elegans) Genes (C. elegans) 
Activation:  
Fatty acid Æ Fatty 
acyl CoA 
Acyl CoA 
Synthetase 
(Long-chain) 
ACSL1, ACSL3, 
ACSL4, ACSL5, 
ACSL6 
(Bubblegum Family) 
ACSBG1, ACSBG2 
Acyl CoA Synthase acs-1, acs-2, acs-3, 
acs-4, acs-5, acs-13, 
acs-15, acs-16, acs-
17, acs-18 (long-chain) 
Transport: Fatty 
acyl CoA Æ L-
palmitoyl carnitine 
Carnitine palmitoyl 
transferase 
CPT1A, CPT1B, 
CPT1C 
Carnitine palmitoyl 
transferase 
cpt-1 
Transport: L-
palmitoyl carnitine 
Æ acyl CoA 
Carnitine palmitoyl 
transferase 
CPT2 Carnitine palmitoyl 
transferase 
cpt-2 
Dehydrogenation 
(first): Acyl CoA Æ 
Trans-2-enoyl CoA 
Acyl Co-A 
dehydrogenase 
(ACAD) 
ACADS (short chain) 
ACADSB 
(short/branched chain) 
ACADM (medium 
chain) 
ACADL (long chain) 
ACADVL (very long 
chain) 
Acyl Co-A 
dehydrogenase 
(ACDH) 
acdh-1 (short-chain), 
acdh-3 
(short/branched 
chain), acdh-4 
(short/branched 
chain), acdh-7 
(medium chain), acdh-
8 (medium chain), 
acdh-10 (medium 
chain), acdh-12 (very 
long chain) 
Hydration: Trans-2-
enoyl CoA Æ 3-
hydroxy acyl CoA 
Enoyl CoA 
hydratase 
ECHS1 (short chain) Enoyl-CoA hydratases ech-6 (short chain) 
Hydroxy acyl CoA 
dehydrogenase/3-
ketoacyl CoA 
thiolase/enoyl CoA 
hydratase 
(trifunctional 
protein), alpha 
subunit 
HADHA Enoyl-CoA 
hydratases/long-chain 
3-hydroxyacyl-CoA 
dehydrogenase 
ech-1.1, ech-1.2 
Dehydrogenation 
(Second): 3-
hydroxy acyl CoA 
Æ 3-keto acyl CoA 
Hydroxy acyl CoA 
dehydrogenase 
HADH Hydroxy acyl CoA 
dehydrogenase 
F54C8.1, hacd-1, 
B0272.3 
Hydroxy acyl CoA 
dehydrogenase/3-
ketoacyl CoA 
thiolase/enoyl CoA 
hydratase 
(trifunctional 
protein), alpha 
subunit 
HADHA Enoyl-CoA 
hydratases/long-chain 
3-hydroxyacyl-CoA 
dehydrogenase 
ech-1.1, ech-1.2 
Acetyl CoA 
transferase 
ACAA2 Acetyl CoA transferase acaa-2 
Thiolytic cleavage: 
3 keto acyl CoA Æ 
Acetyl CoA  
Ketoacyl CoA 
thiolase beta-
subunit of 
trifunctional protein 
HADHB Ketoacyl CoA thiolase 
beta-subunit of 
trifunctional protein 
 
B0303.3 
3-keto acyl CoA 
thiolase 
kat-1 
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1.5.1.1. Acyl CoA Synth(et)ases (ACS) 
In humans, approximately 26 ACS enzymes have been identified and 
characterized or predicted to date (Watkins et al., 2007). These enzymes 
catalyze thioesterification of FA into fatty acyl CoA which can either enter the 
beta-oxidation pathway or other pathways that form membrane phospholipids, 
cholesterol esters and activation of certain transcriptional and signaling 
pathways as shown in Figure 4 (Cooper et al., 2015). 
 
Figure 4. Metabolic reactions of acyl-CoAs. Long-chain FAs are synthesized de novo from 
acetate or enter cells from the plasma. They are converted to acyl-CoAs by ACSL and 
ACSVL. The reaction is reversed by acyl-CoA thioesterases (ACOT). Acyl-CoAs can be 
elongated and desaturated, converted to acylcarnitines, and metabolized to CO2 via 
mitochondrial and peroxisomal enzymes, esterified to glycerol-3-phosphate to form 
lysophosphatidic acid (LPA), phosphatidic acid (PA), and TAG, and esterified to 
monoacylglycerol (MAG) to form diacylglycerol (DAG). Both phosphatidic acid and 
diacylglycerol are precursors for all the glycerophospholipids. Acyl-CoAs are also esterified to 
retinol and cholesterol, acylated to proteins, and incorporated into ceramide to form 
sphingolipids. Lipolysis of these products releases FA back into cellular pools. Triacylglycerol, 
cholesterol esters, and retinol esters are stored in lipid droplets within cells or secreted from 
specialized cells as lipoproteins or milk constituents. NEFA, non-esterified fatty acid. Reused 
with permission from “Physiological Consequences of Compartmentalized Acyl-CoA 
Metabolism”, by Cooper et al., 2015, Copyright 2015, by the American Society for 
Biochemistry and Molecular Biology, Inc.  
 
 21 
ACS enzymes have been broadly categorized into distinct groups based on 
their substrate-specificity, which is mostly defined by chain length of the FA 
substrate. There has been significant evidence from mice and cell line studies 
to show that members of the ACS family exhibit preference for specific chain 
lengths of FA. For example, Li et al. (2009) performed liver-specific knockout 
experiments in mice to show that ACSL1 is important for oxidation of long 
chain FA in the mitochondria. Another study (Marszalek et al., 2005) found 
that ACSL3, ACSL4 and ACSL6 preferentially activate PUFA for oxidation.  
 
The C. elegans genome encodes at least 22 ACSs (WormBase) but there 
have been very few studies characterizing these enzymes and their roles in 
fat metabolism. One study looking at acs-3, which is predicted to encode a 
long chain ACS, showed that it has a role in regulating fat storage (Mullaney & 
Ashrafi, 2010) and acs-4 and acs-5 were shown to be involved in the 
serotonergic regulation of fat storage in C. elegans (Srinivasan et al., 2008). 
For most of these genes, there has been no recorded lf phenotype, and their 
functions (including their roles in beta-oxidation) and substrate-specificity 
have been predicted solely based on their orthology/homology to human or 
mouse ACS genes. 
 
1.5.1.2. Carnitine Palmitoyl Transferases (CPT) 
Carnitine palmitoyl transferases (CPTI and CPTII) transport long chain fatty 
acyl CoAs across the mitochondrial matrix for oxidation. CPTI is located on 
the outer mitochondrial membrane and, since it catalyzes the rate-limiting step 
of FA oxidation (transport of fatty acyl carnitine), it is regulated tightly by 
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malonyl CoA, which is the first intermediate product in FA synthesis. This 
allows for a physiological balance between FA synthesis and degradation. 
CPTII is located on the inner mitochondrial membrane as a membrane-
associated enzyme that facilitates reconversion of long-chain fatty acyl 
carnitine into fatty acyl CoA once it enters the matrix. In humans, CPTI (gene: 
CPT1) and CPTII (gene: CPT2) have been studied extensively both with 
respect to structural and functional characterization (Woldegiorgis et al., 2000; 
Yamzaki, 2004) and their roles (particularly CPT1) in various neurological 
(Virmani et al., 2015; Xie et al., 2016) and metabolic diseases (Flanagan et 
al., 2010; Schreurs et al., 2010).  
 
There are 6 members in the CPT family encoded in the C. elegans genome 
(WormBase), of which cpt-1 and cpt-2 are orthologous to the human CPT1A 
and CPT2 genes respectively, while the other CPT genes (cpt-3,4,5,6) are 
predicted to also have acyl CoA transferase function. The literature available 
on this family of genes is mostly in the area of fat, adiposity and lipid 
metabolism regulation (Brock et al., 2007) by specific transcription factors 
such as nhr-49 (Van Gilst et al., 2005b) and mdt-15 (Taubert et al., 2006) 
through altering expression levels of these CPT genes. 
 
1.5.1.3. Acyl CoA dehydrogenases (ACAD/ACDH) 
ACAD/ACDH, as the name implies, catalyze the dehydrogenation of fatty acyl 
CoA once it enters the mitochondria. These are flavoprotein enzymes that 
require flavin adenine dinucleotide (FAD) as a co-factor to catalyze reactions. 
Nine major ACADs have been identified in eukaryotes, with five of these 
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involved in beta-oxidation of FA (SCAD, MCAD, LCAD, vLCAD, vLCAD2), 
and the other four involved in the catalysis of branched-chain amino acid 
synthesis (i2vD, i3vD, GD, iBD) (Ghisla & Thorpe, 2004). Based on their 
substrate specificity, the ACADs participating in beta-oxidation can be 
categorized into four groups but there is a certain degree of overlap in their 
substrate chain-lengths: (1) short-chain ACAD (SCAD) that preferentially act 
on C4-C6 fatty acyl-CoAs (2) medium-chain ACAD (MCAD) which catalyzes 
dehydrogenation of C6-C10 fatty acyl-CoAs (3) long-chain ACAD (LCAD) 
which acts on C10-C14 fatty acyl-CoAs and (4) very long-chain ACADs 
(vLCAD, vLCAD2) that is specific to C14-C20 fatty acyl-CoAs (Leslie et al., 
2014). Since deficiencies of these enzymes in humans lead to serious 
metabolic consequences that can be detected in newborn screening, they 
have been well-studied and numerous groups have performed protein 
crystallization, functional analyses and gene knockout studies in animal and 
cell models.  
 
However, in C. elegans, which has 13 ACDH genes (WormBase), a detailed 
crystal structure analysis has been performed only on acdh-11. Li et al., 
(2010) reported that while acdh-11 shares 26% protein sequence identity with 
the human vLCAD, it is quite different from its human homolog in terms of 
structural properties. It shows affinity for C11/C12-FA but does not appear to 
have dehydrogenase activity, which suggested that acdh-11 could be involved 
in sequestering long chain FA (specifically C11/C12), and thus may play a 
role in regulation of FA desaturation (Ma et al., 2015). This differential in 
function of acdh-11 and its lack of dehydrogenase activity could explain the 
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low percentage of protein sequence similarity it shares with the human 
VLCAD. The other ACDH enzymes in C. elegans that have been found to be 
orthologous to the five different human ACADs are: acdh-1, acdh-2 (short-
chain), acdh-3, acdh-4 (short/branched chain), acdh-7, acdh-8, acdh-10 
(medium chain), acdh-5, acdh-6 (long chain) and acdh-12 (very long chain). 
acdh-13, although predicted to possess ACDH activity, does not have a clear 
human ortholog. 
 
1.5.1.4. Enoyl CoA hydratase (ECH), 3-hydroxy acyl CoA dehydrogenase 
(HACD/HADH) and 3-keto acyl CoA thiolase (KAT): 
These three classes of enzymes together catalyze the final steps of 
mitochondrial beta-oxidation. ECH catalyzes the addition of one H2O molecule 
to trans-2-enoyl CoA to form 3-hydroxy acyl CoA thioester (Agnihotri & Liu, 
2003), which is subsequently acted upon by HACD/HADH to form 3-keto acyl 
CoA, it is then cleaved by KAT, resulting in acetyl CoA and an acyl CoA 
molecule that is shortened by two carbons. 
 
Like the ACADs, these enzymes also exhibit substrate-specificity based on 
chain length of acyl CoA. The long chain fatty acyls CoAs are metabolized by 
long-chain 2,3-ECH (LYHD), long-chain hydroxy acyl coA dehydrogenase 
(LCHAD) and long-chain KAT (LKAT). As the chain length of the substrate 
shortens, short-chain 2,3-ECH (SHYD), a medium/short-chain L-3-
hydroxyacyl-CoA dehydrogenase (M/SCHAD), and medium-chain, short-chain 
KAT (MKAT, SKAT) are activated to complete the oxidation (Bennett et al., 
1996; Wanders et al., 1999). 
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In higher eukaryotes, the three enzymes catalyzing the final steps of 
mitochondrial beta-oxidation for long-chain fatty acyl CoA (LHYD, LCHAD and 
LKAT) exist as one trifunctional membrane-bound protein complex called the 
Mitochondrial Trifunctional Protein (MTP). This protein complex contains four 
alpha and four beta subunits; the alpha subunits are responsible for the 
ECH/HADH activity while the beta subunits carry out the thiolytic cleavage 
(Rakheja et al., 2002). The alpha subunit is encoded by the HADHA gene and 
the beta subunit is catalyzed by the HADHB gene. Mutations in these two 
genes cause LCHAD and MTP deficiencies in humans, the former being more 
common (Ushikubo et al., 1996).  
 
C. elegans genes encoding the enzymes catalyzing these last three steps 
include the ECH family, hacd-1 and kat-1. The ECH family in C. elegans has 
10 members, and among these ech-1.1 and ech-1.2 are orthologs of the 
human MTP and have ECH/long-chain HADH activity. ech-6 and ech-7 are 
orthologous to the human short-chain ECH, ECSH1. ech-8 and ech-9 are 
predicted to function in the peroxisomes due to their similarity to the human 
bifunctional protein EHHADH which exhibits ECH and HADH enzyme activity 
and is involved in peroxisomal oxidation of FA. ech-4, containing an acyl CoA 
binding domain and ECH domain, has been shown to affect the beta-oxidation 
of unsaturated FA (Elle et al., 2011). There is not enough information on ech-
3 and ech-5 to determine if they have a role in beta-oxidation. 
 
1.6. Goal of Present Study 
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My goal in this project was to characterize the role of mitochondrial beta-
oxidation in the behavioral response to ethanol using C. elegans. Using the 
results of Dr. Alaimo’s microarray data (of ethanol responsive genes), and his 
observations of the effects of loss of function of acs-2 and ech-6 genes of 
mitochondrial beta-oxidation on ethanol response behaviors as preliminary 
data, we asked how mitochondrial beta-oxidation either through its substrates, 
products, intermediate compounds or enzymes plays a role in mediating 
ethanol responses in C. elegans. For this purpose, we selected candidate 
genes that catalyze each step of the pathway based on specific criteria and 
performed behavioral assays on the lf mutants of these genes to determine 
their ethanol response phenotype. We hypothesized that some of these 
mutants would exhibit altered ethanol response phenotypes compared to the 
WT, which would indicate that those genes have a role in the behavioral 
responses to ethanol. 
 
1.7. Specific Aims 
1. Selection of candidate genes in the mitochondrial beta-oxidation 
pathway for testing in ethanol response assays. 
2. Behavioral testing of backcrossed lf mutant strains and RNAi-fed 
worms using locomotion assays, to determine the roles of candidate 
genes in altering ethanol response phenotypes 
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2. MATERIALS AND METHODS 
 
2.1  Selection of candidate genes 
The first aim of the project was to select candidate genes of interest in the 
mitochondrial beta-oxidation pathway, which could be tested for a role in 
ethanol response behavior. I performed a review of literature on mitochondrial 
beta-oxidation of FA and found that there were several versions of the 
mitochondrial beta-oxidation pathway (in humans and C. elegans) in various 
published articles. Though the steps of the pathway were consistent across 
publications, there was significant variation in the enzymes and genes 
catalyzing each step. Therefore, to obtain an exhaustive list of genes involved 
in this pathway, I decided to use the mitochondrial beta-oxidation pathways of 
human (http://www.genome.jp/kegg-bin/show_pathway?hsa00071) and 
C. elegans (http://www.kegg.jp/kegg-bin/show_pathway?cel00071) illustrated 
on the KEGG Pathway database, as these were the most comprehensive 
annotated versions available. We then formulated specific exclusion criteria 
based on which genes would be eliminated from this list. All genes that could 
not be eliminated based on the exclusion criteria were included in the list of 
candidate genes to be tested for their roles in responses to ethanol. The 
exclusion criteria were: strong (literature) evidence showing that the gene 
does not play a role in mitochondrial beta-oxidation, genes that were shown to 
have a role in biological processes unrelated to mitochondrial beta-oxidation 
and genes that were orthologous to human genes that were not involved in 
mitochondrial beta-oxidation of FA. For example, acs-8 aka mec-18, is one of 
the genes in the ACS family. It is expressed only in touch cells and is involved 
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in sensory mechanotransduction and therefore is highly unlikely to play a role 
in beta-oxidation of FA. 
 
For the second aim, prior to testing for ethanol response behaviors, I 
backcrossed the 23 lf mutants obtained from the Caenorhabditis Genetics 
Center (CGC) at least twice (2x) to N2 (WT) worms. Two of the 23 mutants, 
kat-1 and ech-7 were already backcrossed 6x and 10x respectively. So kat-1 
was not backcrossed further. However, the ech-7 lf mutant carried a deletion 
in another gene, paqr-2, so this strain was backcrossed to N2 once more. 
Prior to testing, I ensured that the paqr-2 variant allele was removed from the 
background using PCR with primers for the paqr-2 allele to genotype the F1 
and F2 offspring obtained from the backcross, and maintained the F2s that 
had the mutant ech-7 allele and the WT paqr-2 allele. 
 
2.2  Maintaining strains 
Worms were maintained on petri plates containing nematode growth media 
(NGM). After seeding the plates with OP50, which is a strain of E. coli used in 
the laboratory as food source for C. elegans (refer ‘seeding plates with 
OP50’), five adult hermaphrodites (of N2, the WT strain used in lab) were 
plated on to seeded plates and stored at 20°C. For the mutant strains, six to 
eight adult hermaphrodites were maintained at 20°C. VC2240: Since the 
homozygous mutant of this strain is sterile, it is balanced by a GFP-carrying 
balancer, hT2 [bli-4(e937) let-?(q782) qIs48] (I;III). For this strain, 
heterozygote adults with GFP were picked for maintaining the strain.  
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2.3  Chunking 
This was done to maintain the mutant strains obtained from the CGC and also 
to salvage worms from starved plates. A small chunk of NGM agar (from the 
CGC/starved plates) was cut out using a spatula that was first sterilized using 
70% ethanol and flamed, and the chunk was placed on the edge of the OP50 
lawn on a seeded plate. The chunked plate was left on the bench for a few 
hours; this allows worms from the chunk to crawl onto the OP50 lawn. These 
worms are then transferred to another seeded plate and maintained. 
 
2.4  Making OP50   
OP50 is the strain of E. coli that worms are fed when being maintained in lab. 
A single colony of OP50 was picked using an inoculation loop from the OP50 
stock culture plate and stirred into 50 mL of autoclaved LB. This was then 
allowed to grow overnight (~16 hours) at 37°C, with the lid of the container 
screwed on loosely, to allow for aeration. After ~16-20 hours the culture was 
removed from 37°C and shaken or swirled to check if the LB has turned 
cloudy, which indicates bacterial growth. It was then stored at 4°C for future 
use. OP50 was typically used within 30-45 days after preparation. 
 
2.5  Seeding plates with OP50 
Approximately two drops of OP50 were pipetted onto the NGM plates and 
spread into a square lawn on the center of the plates and allowed to typically 
grow overnight at room temperature before using the plates for maintaining 
worms.    
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2.6  C. elegans strains 
Table 2. List of C. elegans strains used for the project. The genotype (Gene, allele, 
chromosome) is depicted for each strain and the gene of interest is highlighted. The strains 
generated by EMS mutagenesis for the Million Mutations Project (MMP) carry numerous 
mutations and are indicated by the acronym MMP next to the strain name. For these strains, 
only the genotype of interest is given.  
Strain Name Genotype Effect on protein 
N2 (var. Bristol) WT NA 
VC40812 (MMP) acs-3(gk826522)V Y324Ochre 
VC2240  acs-4(ok2872)III/hT2 [bli-4(e937) let-
?(q782) qIs48] (I;III) 
Insertion/deletion (affects 
coding exon and intron) 
RB2015  Y76A2B.3(ok2668)III Deletion (not curated) 
RB2147  acs-13(ok2861)I Deletion (affects coding exon 
and intron) 
RB1377 acs-17(ok1562)X Deletion (not curated) 
VC20634 (MMP) acs-22(gk364606)V R597Opal 
R470Opal 
R600Opal 
VC20616 (MMP) cpt-3(gk356297)III Q636Amber 
VC40798 (MMP) cpt-4(gk818803)V S519Opal 
VC40360 (MMP) cpt-6(gk594576)V W39Opal 
VC1087 acdh-1(ok1514)I Deletion (not curated) 
VC20502 (MMP) acdh-2(gk143151)II W19Opal 
G125E 
W185Opal 
VC40973 (MMP) acdh-5(gk907299)I Q146Amber 
VC40929 (MMP) acdh-6(gk886629)III W51Opal 
VC40288 (MMP) acdh-7(gk556025)X Q361Ochre 
VC40665 (MMP) acdh-11(gk753061)III L119Amber 
L110Amber 
VC41029 (MMP) F54D5.7(gk936057)II W169Opal 
VC40235 (MMP) ech-1.2(gk527451)I Q142Ochre 
Q142Ochre 
Q116Ochre 
QC119 ech-7(et6)I; paqr-2(tm3410)III V175M 
RB2101  R09B5.6(ok2776)V Deletion (affects coding exon 
and intron) 
RB1606  ife-1&F53A2.7(ok1978)III Insertion (affects coding exon 
and intron) 
VC2462 T02G5.4(ok3160)II Insertion (not curated) 
RB2566  T02G5.7(ok3574)II Deletion (not curated) 
VS24 kat-1(tm1037)II Insertion (affects coding exon 
and intron) 
 
2.7  DNA Isolation 
DNA isolation was performed in order to obtain genomic DNA that was used 
as the template for PCR. 
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2.7.1 DNA Isolation for PCR 
A full plate of worms (obtained by plating five adult hermaphrodites on a 
seeded plate and letting them grow and produce a population for three days) 
was used for DNA isolation. These worms were washed off the plate using 
~1.7 mL ddH2O into a 1.5 mL Eppendorf tube and centrifuged at 21,000 rcf 
(high speed) for 30 seconds. Most of the supernatant was removed, and one 
mL ddH2O was added and centrifuged again for one min. The supernatant 
was removed until 0.1 mL of solution remained in the tube. The pellet was 
disturbed by shaking and the tube was placed at -80°C for 15 minutes to lyse 
the cells. Thirty three microlitres of a master mix made of lysis buffer and 10 
mg/mL Proteinase K (35 μL lysis buffer + [(12/1000) x 35] μL Proteinase K) 
was added to the tube. The tube was incubated at 60°C for 90 minutes to 
digest the proteins, followed by a 20 minute incubation at 95°C to inactivate 
the Proteinase K. This lysate containing DNA was stored at -20°C (detailed 
protocol and recipes for solutions used are in Appendix I). 
 
2.7.2 DNA Isolation for Single Worm PCR (SWPCR) 
A master mix of 95 μL lysis buffer and five microlitres of 10 mg/mL Proteinase 
K was prepared and three microlitres of this solution was added to a 0.2 mL 
PCR tube. A single worm (on which PCR is to be performed) was placed in 
the solution and the tube was placed at -80°C for 20 minutes, followed by a 
60 minutes incubation at 60°C and 15 minutes at 90°C. The DNA prepared 
was stored at -20°C (detailed protocol in Appendix I).  
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2.8  Polymerase Chain Reaction (PCR)  
 PCR was performed on all the mutant strains received from the CGC to 
confirm presence of mutant allele in the strains and for genotyping the F1 and 
F2 generations of backcrossed mutant strains. 
 
2.8.1 Primers for PCR 
Primer sequences were obtained from the  website (https://cgc.umn.edu) for 
some mutant strains (Appendix II, Table 14), and for strains that did not have 
this information on the CGC or WormBase, I designed primers using the NCBI 
Primer-BLAST tool (www.ncbi.nlm.nih.gov/tools/primer-blast) using the DNA 
sequence of mutant strains obtained from WormBase (Appendix II, Table 15). 
The DNA sequence in the mutated region (that is either deleted or carries a 
complex substitution in the mutant strain) along with the flanking sequences 
(a few hundred base pairs on either side) was used to generate primers and 
the best primer pair was chosen based on primer length (optimal length of 
PCR primers is 18-22 base pairs, which is long enough for adequate 
specificity and short enough for primers to bind easily to the template at the 
annealing temperature), optimum melting temperature (temperature at which 
one half of the DNA duplex will dissociate to become single stranded and 
indicates the duplex stability. Primers with melting temperatures in the range 
of 52-58°C produce the best results) and self-complementarity (predictive of 
the tendency of primers to anneal to each other, which hinders amplification of 
template DNA).   
 
2.8.2 PCR Setup 
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Unless mentioned otherwise, all polymerase chain reactions (PCR) were set 
up according to the following specifications (see Appendix I for detailed 
protocol): 
Table 3. PCR Reaction components 
Component Volume per sample (μL) Final concentration 
ddH2O 6.7 -- 
10X DreamTaq Green Buffer 1.0 1X 
DreamTaq DNA polymerase 
(5U/μL) 
0.1 0.5 U 
dNTP (10mM) 0.2 2 mM 
Forward Primer (10μM) 0.5 5 μM 
Reverse Primer (10μM) 0.5 5 μM 
DNA  1.0 -- 
 
Table 4. Standard PCR conditions 
Condition Temperature Time 
Initial Denaturation 94°C 2 minutes 
Denaturation 
Annealing 
Extension 
94°C 
45-69°C* 
72°C 
15 seconds 
45 seconds 
1 minute/kb* 
Final Extension 72°C 5 minutes 
*Annealing temperature and extension time vary depending on melting temperature of 
primers (Tm) and product size respectively. 
 
2.8.3 Temperature gradient PCR  
A trial PCR was set up for each of the primer pairs at 5-6 different annealing 
temperatures within a specific range that were picked based on the melting 
temperature of each primer pair using one microlitre of N2 DNA as template, 
to determine the optimal annealing temperature for each primer pair. The 
PCR reaction mix and the PCR program were set up as mentioned in section 
2.8.2. Based on the band intensity (indicates robust amplification) and minimal 
non-specific bands (due to smaller non-specific amplification or primer-
35 cycles 
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dimers) when the PCR product is run on an Agarose gel, the best temperature 
was determined and used as annealing temperature for that primer pair for 
further PCR reactions. 
 
2.8.4 Single worm PCR (SWPCR)  
SWPCR was mainly performed to determine genotypes of progeny from 
crosses (see Appendix I for detailed protocol).  
Table 5. PCR reaction components for SWPCR 
Component Volume per sample (μL) Final concentration 
ddH2O 13.4 -- 
10X DreamTaq Green Buffer 2.0 1X 
DreamTaq DNA polymerase 0.2 0.5 U 
dNTP (10mM) 0.4 2 mM 
Forward Primer (10μM) 1.0 5 μM 
Reverse Primer (10μM) 1.0 5 μM 
DNA 3.0 -- 
 
The three microliters DNA isolated from a single worm (refer to section 2.7.2) 
is used as template DNA to which 18 μL of the master mix is added. The PCR 
program is set up as detailed in 2.8.2. 
 
2.9  Restriction digestion 
For mutants that contain a single nucleotide polymorphism (SNP) within a 
restriction site, PCR was followed by restriction digestion to determine 
genotype of the SNP, using the appropriate restriction enzyme. The restriction 
digestion mix was set up as shown in Table 6, for a final volume of 10 μL. 
This type of genotyping using restriction digestion to detect Single Nucleotide 
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Polymorphisms (SNP) is called snipSNP. Restriction enzymes recognize and 
cleave (or ‘snip’) specific sequences of nucleotides. I chose particular 
enzymes that cut at nucleotide sequences, which contain the WT or variant 
allele at the target SNP, so that digestion using this enzyme resulted in 
cleaving of the amplicon at the SNP, in either the WT allele carriers or mutant 
allele carriers. Detection of genotype was based on the number of fragments 
and size of fragments observed when the digested PCR products were run on 
an Agarose gel. The list of restriction enzymes and digest conditions used are 
given in Table 16, Appendix II. 
Table 6. Restriction digestion reaction mix components 
Component Volume per sample (μL) 
ddH2O 3.5 
Buffer* 1.0 
Restriction enzyme 0.5 
PCR product 5.0 
*Manufacturer guidelines were followed for buffer volume in case of buffer 
concentrations other than 10X and for setting up the digest conditions 
(temperature and time). 
 
2.10  Agarose Gel Electrophoresis 
We used Agarose gel electrophoresis for the following: to determine product 
sizes of amplified DNA fragments in WT and mutant worms to determine 
genotype based on the difference in product size (in case of mutants carrying 
deletions, the size of the amplified product in mutant worms would be smaller 
compared to that of WT worms); to determine the fragment size of restriction 
digested PCR products; for detecting genotype in snipSNP by running the 
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restriction digested fragments on a gel; to estimate the concentration of DNA 
in PCR samples sent for sequencing. The Agarose gels used for this project 
were 1% (if the predicted product size was greater than 600 bp), 1.5% (300-
600 bp, if the predicted product sizes differed by at least 100 bp) and 2% (50-
300 bp, if the predicted product sizes differed by at least 50bp). An Agarose 
gel was prepared using a specific amount of Agarose (depending on the 
percentage and size of the gel, for example, to prepare a 1% large gel of 100 
mL, 1g of Agarose was used). The Agarose was dissolved in a specific 
volume of 0.5X TBE (Tris/Borate/EDTA) buffer and the solution was heated 
until the Agarose dissolved completely in the buffer. Three microliters 
Ethidium Bromide, a DNA-intercalating agent, was added to this and the gel 
was poured into a gel tray that has combs (to form lanes). This setup was 
allowed to cool down, the combs were removed and the gel was placed in a 
gel tank containing 0.5X TBE buffer. Five microlitres of sample (PCR 
product/digested sample) was loaded into each lane and an appropriate DNA 
ladder was used to serve as a guideline to determine the size of sample 
bands. The gel was run at a set voltage (80V-100V) for 45-120 minutes 
(depending on size of fragments) and then visualized in the UV 
transilluminator to determine band sizes of samples and estimate DNA 
concentration. 
 
2.11  DNA sequencing 
Sanger sequencing was performed for SNPs that were not detectable by 
restriction digestion or PCR. Sequencing was also used to confirm the results 
obtained by restriction digestion or PCR, in case of ambiguous results or 
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failed digests. PCR was performed using primers flanking the SNP to 
generate a reaction volume of 10 μL (in case of SWPCR, 21 μL). The 
concentration of DNA was estimated from running the samples on an Agarose 
gel and comparing the band intensity to a DNA ladder (of known band sizes 
and DNA concentrations). Two microlitres of ExoSAPTM (a PCR product 
cleanup reagent) was added to five microliters of PCR product and incubated 
at 37°C for 15 minutes, to degrade excess primers and dNTPs, followed by 15 
minutes incubation at 80°C to inactivate the ExoSAP reagent. The 
sequencing reaction was prepared according to the standard guidelines (for 
Sanger sequencing using Purified Template) provided by GENEWIZ 
(Appendix I). The purified PCR product was diluted for a final volume of 10 μL 
and an appropriate final concentration (ng/μl) based on the size of the PCR 
product (see Table 12 in Appendix I). Five microlitres of diluted forward primer 
(1 in 20 dilution: 95 μL ddH2O and five microliters 100μM primer) was added 
to the diluted, purified PCR product to make up a 15 μL sequencing reaction. 
All sequencing reactions thus prepared were sent to the GENEWIZ facility for 
Sanger sequencing. 4Peaks software was used to interpret SNP genotype by 
visualizing the sequence trace files received from GENEWIZ. 
 
2.12  RNA interference (RNAi) 
 All the RNAi experiments were performed based on the protocol published by 
(Kamath et al., 2003). I planned to perform RNAi for 14 candidate genes that 
did not have lf mutants available from CGC. Bacterial clones containing the 
sequences coding for double stranded RNA complementary to the genes of 
interest were obtained from the RNAi library generated by Ahringer. The RNAi 
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bacterial strain was not available in the library for one of the genes (cpt-1). For 
the other 13 genes, the corresponding bacterial colony was scraped using a 
micropipette tip and suspended in 2 mL of LB containing 50 μg/mL Ampicillin. 
This was also done for dpy-17, which we used as a positive control used for 
RNAi and L4440, which is the empty bacterial vector (used as ‘WT’ control for 
behavioral assays). These cultures were allowed to grow for 16 hours by 
incubating in the shaker at 37°C and 250 rpm (Appendix I: Making RNAi 
cultures from frozen stock). Five of the 13 RNAi cultures did not show any 
growth (acs-15, acs-18, acdh-3, F54C8.1, B0272.2) and hence the process 
was repeated for these, with no success. One and half milliliters of the other 
grown cultures were used for freezing by adding 300 μL of glycerol, in cryo-
tube vials (Appendix I: Freezing RNAi Cultures). The grown bacterial cultures 
were also streaked on LB plates containing Ampicillin (50 mg/mL) and 
Tetracycline (15 mg/mL) using an inoculation loop, and incubated at 37°C for 
16 hours (Appendix I: Preparing ampicillin + tetracycline plates for RNAi). 
These plates were then stored at 4°C and used for preparing liquid cultures of 
RNAi. Single colonies were picked from the plates and suspended in five 
milliliters of LB containing 50 μg/mL Ampicillin and grown for 16 hours in the 
shaker at 37°C and 250 rpm to obtain cultures that were ready to be used for 
feeding worms. Prior to performing behavioral assays, the bacterial clones in 
each of these cultures were confirmed by Sanger sequencing. For this, three 
milliliters of the culture was used for DNA extraction, which was performed 
using the Invitrogen PureLink HQ Mini Plasmid Purification Kit (Appendix I: 
Plasmid DNA extraction using Invitrogen PureLink HQ Mini Plasmid 
Purification Kit) and the plasmid DNA was quantified using a NanoDrop 
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machine (DNA concentrations are attached in Appendix II, Table 17). The 
samples were prepared for sequencing according to the requirements given 
on GENEWIZ for Purified Templates (Appendix I: Sanger sequencing sample 
preparation using Plasmid DNA template). DNA was diluted to a final 
concentration of 50 ng/μL in 10 μL and five microliters of diluted (1 in 20 
dilution) UC19 primer was added to each diluted sample. Sanger sequencing 
was done by GENEWIZ and the sequences obtained were input in NCBI 
BLAST to confirm the gene sequence. All samples had the correct sequence 
except acs-16, for which sequencing was not successful due to lack of 
priming (this was repeated once, but with the same outcome). Therefore, 
RNAi bacterial cultures were successfully grown and confirmed for seven 
genes (W03F9.4, acdh-4, acdh-8, acdh-10, acdh-12, ech-1.1, B0303.3) for 
which behavioral assays on ethanol were performed.  
For the confirmed gene sequences, 800 μL of each RNAi culture was seeded 
on NGM plates containing Carbenicillin (50 mg/mL) and IPTG (0.1 M) 
(Appendix I: Carbenicillin Plates for RNAi). N2 worms in the L4 stage were 
placed on each of these RNAi plates approximately 24 hours before the 
behavioral assay on ethanol was to be performed. The dpy-17 RNAi was used 
as a positive control to confirm that RNAi setup was functional (the worms fed 
with dpy-17 RNAi culture exhibited ‘dumpy’ phenotype, and at least three-
fourths of the worms on this plate need to be ‘dumpy’ for the RNAi to be 
considered successful). This was done each time new RNAi cultures were 
made or new RNAi plates were prepared. The behavioral assays on ethanol 
were performed as described in section 2.14, using L4440 (N2 worms fed with 
E. coli carrying empty vector) as the WT strain.  
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2.13 Backcrossing mutant strains 
All of the lf mutant strains received from the CGC that were not already 
backcrossed to N2 at least twice, were backcrossed twice to N2 (2x cross) to 
decrease the number of other mutations in the strain that could affect the 
behavioral response to ethanol. These 2x backcrossed mutants were used for 
behavioral assays on ethanol. The ones that showed a significantly different 
ethanol response phenotype compared to N2 were further backcrossed four 
additional times to N2 for a final number of 6x backcrosses. 6x generally will 
generate a mostly WT genetic background (~98.375%) and is the generally 
accepted standard in C. elegans genetics (Boulin & Hobert, 2012; Zuryn et al., 
2010). 
 
Refer to figures 5 and 6 for a graphic step-wise representation of the 
backcross with the genotypes and their ratios at each generation. Figure 5 
represents the backcross for genes on autosomes (chromosomes I-V) and 
figure 6 represents the backcross for genes on the X-chromosome.  
 
I set up Cross I using mutant hermaphrodites in the L4 stage with N2 males 
(in 5:10 ratio) and this is considered as ‘day 1’ of the cross. On the following 
day (day 2), each of the mated mutant hermaphrodite adults were transferred 
to separate freshly seeded plates and allowed to lay eggs. Three days later 
(day 5), five F1 hermaphrodite progeny (which are all heterozygous) were 
transferred to a separate seeded plate from each one of the day 2 plates. 
These plates are stored for backup if the second cross fails and needs to be 
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repeated. Also, on day 5, F1 males from these day 2 plates were used to set 
up a mating with N2 hermaphrodite L4s (in a ratio of 10:5) for Cross II. The 
next day (day 6), each one of the mated N2 hermaphrodite adults from Cross 
II were picked to individual plates and allowed to lay embryos. Four days later 
(day 10), ten or twelve F1 adult hermaphrodites from these plates were picked 
to individual plates and allowed to self-fertilize and lay eggs overnight. 
SWPCR was performed on these F1 hermaphrodites from cross II, on the 
following day (day 11), to determine the genotype. 8-10 F2 hermaphrodites 
(from the heterozygous F1 plate) were picked to individual plates four days 
after PCR, and this was repeated on the next day (day 16) and these are 
allowed to lay eggs overnight. SWPCR was performed on these F2 progeny 
to select the homozygous mutant worms. The embryos from the homozygous 
mutant F2 were used to maintain a population of 2x backcrossed mutant 
worms.  
 
One of the mutant strains (VC2240, acs-4(ok2872)) was balanced by  bli-4- 
and GFP-marked translocation (acs-4(ok2872) III/hT2 [bli-4(e937) let-
?(q782) qIs48] (I;III)), since this is a homozygous sterile deletion. Therefore, 
for backcrossing this strain to WT background, it was first outcrossed to the 
balancer strain (hT2 [bli-4(e937) let-?(q782) qIs48] (I;III), obtained from Dr. 
Laura Mathies), followed by cross to N2. The steps in this cross are shown in 
Figure 7. 
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Figure 5. Genotypes and ratios of outcrossed progeny in the 2x outcross of mutants of genes on the 
autosomes (Chromosomes I-V) 
 
 
 
d1 Mutant hermaphrodite L4 X N2 Adult Male   (Cross I) 
    + 
   + 
mut 
mut 
d2 Singled mated mutant hermaphrodite adult 
 
d5 F1 progeny (50% hermaphrodites; 50% males) 
 mut 
   + 
F1 male X N2 hermaphrodite L4 (Cross II) 
 
   + 
   + 
mut 
   + 
d6  Singled mated N2 hermaphrodite adults 
 
d10 F1 progeny of Cross II (50% hermaphrodites; 50% males) 
 
mut 
   + 
   + 
   + 
(1:1 ratio) 
Singled F1 hermaphrodite adults (allowed to self-fertilize and lay embryos) 
 
 d11 SWPCR of F1 hermaphrodite adults that were allowed to lay eggs 
 
 d15 F2 progeny from heterozygous F1 hermaphrodite adults 
 
   + 
   + 
mut 
   + 
mut 
mut (1:2:1 ratio) 
Singled 8-10 F2 hermaphrodite adults from the heterozygous mutant 
hermaphrodite adults from SWPCR of d11 (allowed to self-fertilize and lay 
embryos) 
 
d16  SWPCR of singled F2 hermaphrodite adults from d15 
 Again singled 8-10 F2 hermaphrodite adults from the homozygous mutant 
hermaphrodite adults from SWPCR of d11 (allowed to self-fertilize and lay 
embryos) 
 
d17 SWPCR of singled F2 hermaphrodite adults from d16 
 Selected worms from the homozygous mutant F2 hermaphrodite adult plates to 
maintain 2x backcrossed mutant strain 
 
 
2x backcross for mutants of genes on Chr I-V 
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Figure 6. Genotypes and ratios of outcrossed progeny in the 2x outcross of mutants of genes on 
the X-Chromosome 
 
 
d1 Mutant hermaphrodite L4 X N2 Adult Male   (Cross I) 
    + 
   o 
mut 
mut 
d2 Singled mated mutant hermaphrodite adults 
 
d5 F1 progeny (50% hermaphrodites; 50% males) 
 mut 
   + 
F1 male X N2 hermaphrodite L4 (Cross II) 
 
   + 
   + 
d6  Singled mated N2 hermaphrodite adults 
 
d10 F1 progeny of Cross II (50% hermaphrodites; 50% males in 1:1 ratio) 
 
mut 
   + 
Singled F1 hermaphrodite adults (allowed to self-fertilize and lay embryos) 
 
 
d15 F2 progeny from F1 hermaphrodite adults 
 
   + 
   + 
mut 
   + 
mut 
mut 
(1:2:1 ratio) 
Singled 8-10 F2 hermaphrodite adults (allowed to self-fertilize and lay embryos) 
 
d16  SWPCR of singled F2 hermaphrodite adults from d15 
 Again singled 8-10 F2 hermaphrodite adults (allowed to self-fertilize and lay 
embryos) 
 
d17 SWPCR of singled F2 hermaphrodite adults from d16 
 Selected worms from the homozygous mutant F2 hermaphrodite adult plates to 
maintain 2x backcrossed mutant strain 
 
 
2x backcross for mutants of genes on X-Chromosome 
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Figure 7. Genotypes of F1 and F2 progeny in the 2x backcross of mutants of balanced mutant 
strain: (acs-4(ok2872) III/hT2 [bli-4(e937) let-?(q782) qIs48] (I;III) 
 
2.14 Behavioral assays on ethanol 
Behavioral assays were performed to measure ethanol response of 
backcrossed lf mutant strains and RNAi-fed worms. 
 
d1 Mutant hermaphrodite L4 (gfp) X N2 Male   (Cross I) 
 
d2 Singled mated mutant hermaphrodite adult 
 
d5 F1 progeny (50% hermaphrodites; 50% males) 
 
Non-gfp F1 male X Balancer hermaphrodite L4 (Cross II) 
 
d6  Singled mated N2 hermaphrodite adults 
 
d10 F1 progeny of Cross II  
50% are non-viable; 25% are ‘dumpy’ (with no gfp) and out of the remaining 25% 
that have gfp, half of them carry the mutant allele for acs-4 and the other half carry 
the WT allele for acs-4. F1 hermaphrodites with gfp were singled and allowed to lay 
eggs.  
 
 
 
d11 SWPCR of F1 hermaphrodite adults that were allowed to lay eggs 
 
 
d15 Singled 8-10 F2 hermaphrodites with gfp from heterozygous (gfp) F1 
hermaphrodite adults and allowed to self-fertilize and lay eggs. 
 
d16  50% of the F2 hermaphrodites are sterile, so do not have eggs on the plate. The 
remaining 50% of F2s are heterozygous for acs-4(ok2872). The heterozygous F2s 
are maintained by gfp as the 2x backcrossed strain. 
 
2x backcross for mutants balanced by a balancer strain 
   + 
   + 
   + 
   + 
   + 
   hT2g 
I 
mut 
   hT2g 
III 
   + 
   + 
I 
mut    + 
III 
   Dpy 5 unc-13 
   hT2g 
I 
 + 
   hT2g 
III 
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The detailed protocol for performing behavioral assays on ethanol is given in 
Appendix I (Ethanol assay with copper rings). Approximately 24 hours before 
the assay, 20 L4s of each strain to be assayed were picked onto a separate 
seeded plate to get age-matched adults. NGM plates (unseeded) were dried 
for 2 hours at 37°C and weighed.  Four copper rings were heated in a flame 
and were placed on the NGM agar in order to confine the worms to a small 
area, which allows us to assay four strains of worms on a plate. Copper is 
used for the rings because C. elegans are repelled by it. A volume of ice-cold 
(refrigerated at 4°C) 100% ethanol corresponding to the plate weight (to 
achieve a concentration of 400mM) was added (Appendix II, Table 18) to one 
of the plates (400mM assay plate). The plate was immediately sealed with 
Parafilm to prevent evaporation of ethanol and ethanol was allowed to 
equilibrate for two hours. Another plate of approximately the same weight was 
used as the ‘control’ 0mM assay plate. Two plates (for 0mM and 400mM) 
were used for acclimation to starve worms for 30 minutes prior to placing 
them on the assay plates. Each assay was performed with three strains of 
mutant worms and N2 as control, with 10 worms of each strain placed in each 
of the four copper rings. 2 minute time-lapse movies to track the locomotion of 
worms on the assay plates (0mM and 400mM) were captured using the 
ImagePro Plus software, at two different time points: 10 minutes and 30 
minutes after worms were placed on the assay plates. The software captured 
12-bit images of worms, one image per second, for 2 minutes (120 images), 
which tracked the movement of worms within each copper ring. Analysis of 
these assays was done using ImagePro Plus to obtain mean/average speeds 
of worms within each copper ring, at different time points, at the two 
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concentrations of ethanol (0mM and 400mM). In the analysis, the software 
was used to analyze speed of individual worms from one second to the next 
(over 120 seconds). The average velocity of each worm and the average 
velocity of all worms within the ring was calculated by the software. This data 
was exported into an excel file. The movies were recorded and analyzed as 
detailed in Appendix I (Computer Tracking and Analyzing Movies). Paired t-
tests were performed on the mean/average speeds at the different time points 
and concentrations of ethanol (from the locomotion assays) using GraphPad 
Prism statistical software to determine initial sensitivity and acute tolerance of 
the mutant strains to ethanol, in comparison to N2/the WT strain.  
Since acute exposure to ethanol is known to have a depressive effect on 
locomotion in C. elegans, we examined the following parameters using paired 
t-tests: a) if the speeds of mutant and WT worms were significantly different in 
terms of relative speeds at 10 minutes after exposure to ethanol (a measure 
of initial sensitivity) b) if the relative speeds of each strain (mutant and WT) 
were significantly different between 10 minutes and 30 minutes after exposure 
to ethanol (a measure of development of AFT) and c) if the recovery 
(difference between relative speeds at 10 minutes and 30 minutes of ethanol 
exposure) of mutant strain was significantly different compared to the 
recovery of WT strain. 
These analyses helped us determine the ethanol responses in mutant strains; 
whether the mutant strain was more or less sensitive to ethanol compared to 
the WT strain and whether the recovery of mutant strain was more or less 
than that of the WT strain. This allowed us to draw inferences about the 
effects of target gene in ethanol response behavior. 
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For all the 2x backcrossed mutant strains, ethanol assays were performed at 
least four times (n=4) and among these, for the ones that did not show 
significant difference in ethanol responses compared to N2, n=6 was done. 
For the 6x backcrossed mutant strains, assays were done six times (n=6). All 
the RNAi fed worms were assayed at least eight times (n=8), since RNAi-
mediated gene knockdown is usually more variable compared to a mutant. 
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3. RESULTS AND DISCUSSION 
 
3.1 Candidate genes in mitochondrial beta-oxidation  
As described in the Materials and Methods section, I began the candidate 
gene selection by identifying all the genes involved in the pathway by 
comparing the human and C. elegans mitochondrial beta-oxidation pathways. 
Based on this comparison, I derived three sets of genes (listed in Table 7): (1) 
genes from the C. elegans beta-oxidation pathway (2) C. elegans orthologs of 
the human beta-oxidation genes, obtained using an ortholog prediction tool, 
DIOPT v5.3 (DRSC Integrative Ortholog Prediction Tool) (Hu et al., 2011), (3) 
all other genes within each family of enzymes catalyzing the mitochondrial 
beta-oxidation pathway (for example, ACS family, ACDH family etc.,) that 
were not included in the human or C. elegans mitochondrial beta-oxidation 
pathways on KEGG.  
Table 7. List of all genes reviewed. ‘On KEGG & DIOPT’ category includes the list of all 
genes that were common between the two sets of genes obtained from C. elegans KEGG 
mitochondrial beta-oxidation and the C. elegans genes that were found to be orthologs of 
human mitochondrial beta-oxidation pathway, using DIOPT. ‘Only DIOPT’ category includes 
the list of genes that were found to be orthologs of human mitochondrial beta-oxidation 
pathway but not included in the C. elegans mitochondrial beta-oxidation pathway. ‘Only 
KEGG’ category includes genes that were found in the C. elegans mitochondrial beta-
oxidation pathway but not found to be orthologs of human mitochondrial beta-oxidation 
pathway, using DIOPT. ‘Neither’ category includes, genes that were members of the enzyme 
families catalyzing mitochondrial beta-oxidation but were not included in either of the above 
groups (KEGG or DIOPT). 
On KEGG & 
DIOPT 
Only DIOPT Only 
KEGG 
Neither 
acs-3 acs-23 acs-2 acs-1 
acs-4 cpt-6 acs-16 acs-6 
acs-5 W03F9.4  acs-7 
acs-13 cpt-3  acs-8 
acs-15 cpt-4  acs-9 
acs-17 acdh-6  acs-10 
acs-18 acdh-5  acs-11 
cpt-1 acdh-2  acs-12 
 cpt-2 ech-7  acs-14 
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acdh-7 T02G5.4  acs-19 
acdh-8   acs-20 
acdh-10   acs-21 
acdh-12   acs-22 
acdh-1   cpt-5 
acdh-3   acdh-9 
acdh-4   acdh-11 
F54D5.7   acdh-13 
ech-1.1   ech-3 
ech-1.2   ech-4 
ech-6    
ech-8    
ech-9    
B0272.3    
F54C8.1    
hacd-1    
acaa-2    
B0303.3    
T02G5.7    
kat-1    
TOTAL NUMBER OF GENES IN EACH CATEGORY 
29 10 2 19 
 
We wanted to include the C. elegans orthologs of human mitochondrial beta-
oxidation genes because this pathway has not been extensively studied in 
C. elegans, and hence it is possible that the roles of some C. elegans genes 
have not yet been identified in mitochondrial beta-oxidation and these would 
not be included in the pathway available on KEGG. There was some overlap 
between these two gene sets i.e., some genes that were found in the 
C. elegans mitochondrial beta-oxidation pathway were also orthologous to the 
human mitochondrial beta-oxidation genes (see Figure 8). The third set of ‘all 
other genes in each enzyme family’ was included to capture potential 
candidate genes that have not been characterized in mitochondrial-beta-
oxidation and have also not been listed as orthologs to any of the human 
mitochondrial beta-oxidation genes in DIOPT, but possess enzymatic activity 
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in mitochondrial beta-oxidation (since they belong in the same family). These 
three sets of genes were reviewed based on the previously defined exclusion 
criteria, and the ones that could not be excluded were considered candidates.  
We did not use inclusion criteria to select candidate genes for this project 
because in order to have a strong basis for inclusion, these genes needed to 
be well characterized for their role in beta-oxidation. But for most of these 
genes there is little evidence implicating them in mitochondrial beta-oxidation. 
Therefore, using inclusion criteria would result in exclusion of majority of these 
genes due to lack of evidence. Lack of evidence does not mean that these 
genes do not have a role in mitochondrial beta-oxidation. So, we used 
exclusion criteria to make sure we did not miss any potential candidates due 
to lack of evidence. Excluded genes are listed in Table 8, along with the 
reason for exclusion for each gene. In retrospect, I am of the opinion that the 
C. elegans orthologs of human short-chain ACS genes (ACSF, ACSS and 
ACSM) should have been been included in the list of candidates. The reason 
for this is that the C. elegans acs-2 gene is an ortholog of the human ACSF2 
and acs-2 was found to have an effect on AFT in response to ethanol in 
C. elegans. This implies that the other acs genes that are orthologs of human 
short chain ACS genes could be potential candidates.  
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Figure 8. Mitochondrial beta-oxidation genes in C. elegans and humans. Two sets of genes were 
obtained by comparing the human and C. elegans mitochondrial beta-oxidation pathway on KEGG 
namely, C. elegans genes orthologous to human KEGG genes (that were determined using DIOPT, 
ortholog prediction tool) and genes from the C. elegans mitochondrial beta-oxidation pathway on 
KEGG. 
 
Table 8. Reasons for exclusion of genes. This table contains a list of all genes that were 
excluded along with the reasons for exclusion. 
Gene Reason for exclusion 
acs-1 Ortholog of ACSF2 which is not included in the human KEGG 
pathway of mitochondrial beta-oxidation 
acs-6 Ortholog of ACSS1 which is not included in the human KEGG 
pathway of mitochondrial beta-oxidation 
acs-7 Ortholog of ACSF2 which is not included in the human KEGG 
pathway of mitochondrial beta-oxidation 
acs-8 (aka mec-18) Irrelevant gene function – encodes protein similar to firefly luciferase. 
Also expressed exclusively in touch cells. Unlikely to be involved in 
mitochondrial beta-oxidation 
acs-9 Ortholog of ACSS1, ACSS3 and ACSM1, ACSM5 - none of these 
genes are included in human KEGG pathway of mitochondrial beta-
oxidation 
acs-10 Ortholog of ACSS1 and ACSS2 – neither of these genes are 
included in human KEGG pathway of mitochondrial beta-oxidation 
acs-11 Ortholog of ACSF3 which is not included in the human KEGG 
pathway of mitochondrial beta-oxidation 
acs-12 Ortholog of ACSF2 and several ACSM genes which are not included 
in the human KEGG pathway of mitochondrial beta-oxidation 
acs-14 Ortholog of ACSF2 which is not included in the human KEGG 
pathway of mitochondrial beta-oxidation 
acs-19 Ortholog of ACSS2 which is not included in the human KEGG 
pathway of mitochondrial beta-oxidation 
acs-20 Orthologs are FATP4 and several other solute carriers which are not 
included in the human KEGG pathway of mitochondrial beta-
oxidation 
acs-21 Ortholog ACSF3, ACSF2 which are not included in the human KEGG 
pathway of mitochondrial beta-oxidation 
acs-23 Annotated as psuedogene on wormbase 
Human mitochondrial β-
oxidation (KEGG) 
C. elegans mitochondrial β-
oxidation (KEGG) 
 
DIOPT 
C. elegans 
genes 
orthologous to 
human KEGG 
genes (10) 
 
C. elegans 
KEGG genes 
(2) 
 
29 
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acdh-9 Ortholog of ACAD8 and IVD - both of these are not included in the 
human KEGG pathway of mitochondrial beta-oxidation - ACAD8 
catalyzes catabolism of valine amino acid in mitochondria, IVD 
catalyzes leucine catabolism; It is also annotated on KEGG as 
isobutyryl-CoA dehydrogenase to be involved in Valine, leucine and 
isoleucine degradation. 
acdh-13 (aka gei-9) Ortholog of human ACOX1 and ACOX2. Both these acyl CoA 
oxidases are involved in peroxisomal beta-oxidation of FA 
ech-8 Ortholog of human EHHADH (ECH and HADH), a bifunctional 
enzyme that catalyzes peroxisomal beta-oxidation of FA 
ech-9 Ortholog of human EHHADH (ECH and HADH), a bifunctional 
enzyme that catalyzes peroxisomal beta-oxidation of FA 
ech-3 Ortholog of ECI1, which is not included in the human KEGG pathway 
of mitochondrial beta-oxidation. It is a peroxisomal auxillary enzyme 
that catalyzes an isomerization step in the oxidation of unsaturated 
fats. 
 
Of the seven genes Dr. Alaimo tested, acs-2 and ech-6 lf exhibited significant 
ethanol responses, so these were not included in the candidate genes list. 
Among the remaining five genes he tested, I included ech-1.1 and ech-1.2 in 
the list of candidate genes and excluded the other three (cpt-2, cpt-5 and ech-
4) based on my exclusion criteria. 
 
Therefore, for the first aim, I performed a review on 60 genes in total (see 
Table 7). I identified that 29 genes were common between the two gene sets 
(see Figure 8), 2 genes were exclusively present in the C. elegans KEGG 
pathway, 10 genes were obtained exclusively from DIOPT as orthologs of the 
human mitochondrial beta-oxidation genes and 19 genes were found in 
neither of the data sets, but reviewed because they were members of one of 
the gene families catalyzing beta-oxidation. Out of these 60 genes, based on 
the predetermined criteria, I excluded 18 genes (see Table 8). In total, I 
excluded 23 genes (18 genes that I reviewed and excluded + two genes (acs-
2, ech-6) that Dr. Alaimo found to have a significant effect on ethanol 
responses + three genes (cpt-2, cpt-5, ech-4) that Dr. Alaimo already tested 
and I excluded). I considered the remaining 37 genes that could not be 
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excluded to be bona fide candidates and ensured that at least one gene in 
each step of the mitochondrial beta-oxidation pathway was included in these 
candidates.  lf mutant strains for 23 of the 37 candidate genes were available 
and we ordered these strains from the CGC. For the other 14 genes we 
decided to perform RNAi-mediated knockdown to test their role in ethanol 
response.  
 
3.2 Ethanol response phenotypes of candidate genes in mitochondrial beta-
oxidation 
All the lf mutants and RNAi-mediated knockdown strains were assayed on 
ethanol for behavioral responses. Twenty-one of the 23 lf mutant strains were 
initially backcrossed twice (2x) and tested for their behavioral responses to 
ethanol (the results for these assays are summarized in Table 9 and the 
graphs are attached in Appendix III). Out of the 21 backcrossed mutants, 13 
showed significantly different ethanol response phenotypes compared to WT 
(N2) and eight of them were not different from N2 in their ethanol responses. 
These eight strains were frozen and stored in the -80°C freezer. The 13 
mutant strains that showed a significant difference were further backcrossed 
to 6x to achieve ~98.375% WT background and eliminate other, not closely 
linked, mutations, to ensure that the effect on ethanol response is likely to be 
due to lf of the candidate gene. These 6x-backcrossed mutants were assayed 
on ethanol to confirm the phenotypes observed in the 2x strains (the results 
for these assays are summarized in Table 10 and the graphs are attached in 
Appendix III). In five (acs-4, acs-13, acs-22, cpt-3 and T02G5.4) of the 13 6x-
backcrossed mutants tested, ethanol responses (initial sensitivity and/or AFT) 
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were no longer statistically significant in their difference from WT. A possible 
reason for this is that the ethanol response phenotypes observed in the 2x 
backcrossed strains could have been due to background mutations that were 
eliminated in the 6x backcross. The remaining 14 candidate genes did not 
have lf mutants available from the CGC, so we decided to perform RNAi to 
knockdown the function of these genes and test them on ethanol. One of the 
genes (cpt-1) was not available in the RNAi bacterial clones library (Ahringer, 
Geneservice, Cambridge, UK), five of the RNAi clones did not grow in culture 
and one RNAi clone did not carry the sequence of the target gene (acs-16). 
Therefore, seven genes were knocked down using RNAi clones and the effect 
of knockdown was tested on ethanol response (the results for these assays 
are summarized in Table 10 and the graphs are attached in Appendix III). 
Only two out of the seven RNAi genes (acdh-10, acdh-12) showed 
significantly different responses to ethanol compared to the L4440 (empty 
bacterial vector) treated worms. Since the effectiveness of RNAi across 
experimental trials and across different genes is not consistent, it is important 
to note that the lack of a significantly different ethanol response phenotype 
does not rule out the remaining five genes as potential candidates that could 
influence ethanol responses.
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Figure 9. Mitochondrial beta-oxidation of FA showing genes tested at each step of the pathway and their 
ethanol response phenotypes: initial sensitivity (S) and AFT (T). The up (↑) arrow indicates more 
sensitive (S) or increased development of AFT (T) compared to WT worms (N2 or L4440) and down (↓) 
arrow indicates a less sensitive (S) or decreased AFT development (T) compared to WT worms. An 
‘equal to’ (=) symbol indicates that the phenotype is not significantly different from that of WT worms. 
Genes that appear to modulate either one of the ethanol responses are highlighted in bold. RNAi 
knockdown genes are in gray font and lf mutants are in black font. Numbers in boxes  
within each box of genes correspond to the following reaction steps, 1: Fatty acid Æ acyl CoA, catalyzed  
by acyl CoA synthetases (ACS) 2: Transport of acyl CoA from cytosol to mitochondria, catalyzed by 
carnitine palmitoyl transferases (CPT) 3: Acyl CoA Æ Trans-2-enoyl CoA, catalyzed by acyl CoA 
dehydrogenases 4: Trans-2-enoyl CoA Æ 3-hydroxy acyl CoA, catalyzed by enoyl CoA hydratases 5: 3-
hydroxy acyl CoA Æ 3-keto acyl CoA, catalyzed by hydroxyl acyl CoA dehydrogenases 6: 3-keto acyl 
CoA Æ acyl CoA(n-2) + acetyl CoA, catalyzed by thiolases.
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Table 9. Ethanol response phenotypes of 2x backcrossed loss of function (lf) m
utants in the m
itochondrial beta-oxidation pathw
ay in C
. elegans. The initial 
sensitivity and AFT values in this table are the relative speeds of the w
orm
s at the 10 m
inute and 30 m
inute tim
e points respectively. The (10’-30’) value for each 
strain represents the difference in relative speeds betw
een the 10 m
inute and 30 m
inute tim
e points, w
hich is a m
easure of the degree of recovery.  
Step catalyzed  
G
enotype 
Initial Sensitivity (IS) 
A
cute Functional Tolerance (A
FT) 
Ethanol response 
phenotypes 
W
T 
M
utant 
Significance 
W
T 
M
utant 
Significance 
Fatty acid Æ
 
Fatty acyl C
oA 
(ATPÆ
AM
P) 
acs-3(gk826522) 
N
2 (10’): 
35.48±2.78%
 
acs-3 (10’): 
26.89±2.046%
 
t6 = 3.36; P = 
0.0437 
N
2 (30’): 
51.19±1.84%
 
N
2 (10’-30’): 
15.71±1.35%
 
acs-3 (30’): 
26.94±1.765%
 
acs-3 (10’-30’): 
0.0400±0.52%
 
t6 = 11.88; P 
= 0.0013 
M
ore sensitive than N
2; 
R
educed AFT than N
2 
acs-4(ok2872) 
N
2 (10’): 
42.90±3.97%
 
acs-4 (10’): 
25.90±2.87%
 
t6 = 5.596; P 
= 0.0025 
N
2 (30’): 
59.30±4.71%
 
N
2 (10’-30’): 
16.39±2.11%
 
acs-4 (30’): 
39.12±4.88%
 
acs-4 (10’-30’): 
13.21±2.056 
t6 = 2.513; P 
= 0.0536 
M
ore sensitive than N
2; AFT 
not different from
 N
2 
acs-5(ok2668) 
N
2 (10’): 
40.61±2.75%
 
acs-5 (10’): 
12.11±1.97%
 
t6 = 7.161; P 
= 0.0008 
N
2 (30’): 
53.07±1.99%
 
N
2 (10’-30’): 
12.46±2.33%
 
acs-5 (30’): 
20.76±3.59%
 
acs-5 (10’-30’): 
8.65±3.99%
 
t6 = 0.6185; P 
= 0.5633 
M
ore sensitive than N
2; N
o 
(significant) developm
ent of 
AFT 
acs-13(ok2861) 
N
2 (10’): 
35.48±2.78%
 
acs-13 (10’): 
49.68±2.67%
 
t4 = 12.36; P 
= 0.0011 
N
2 (30’): 
51.19±1.84%
 
N
2 (10’-30’): 
15.71±1.35%
 
acs-13 (30’): 
64.31±3.05%
 
acs-13 (10’-30’): 
14.63±2.76%
 
t4 = 0.74; P = 
0.5148 
Less sensitive than N
2; AFT 
not different from
 N
2 
acs-17(ok1562) 
N
2 (10’): 
40.61±2.75%
 
acs-17 (10’): 
42.04±2.29%
 
t6 = 0.3281; P 
= 0.7561 
N
2 (30’): 
53.07±1.99%
 
N
2 (10’-30’): 
12.46±2.33%
 
acs-17 (30’): 
51.51±1.50%
 
acs-17 (10’-30’): 
9.47±2.58%
 
t6 = 0.6544; P 
= 0.5418 
IS not different from
 N
2; AFT 
not different from
 N
2 
acs-22(gk364606) 
N
2 (10’): 
37.52±3.28%
 
acs-22 (10’): 
38.35±2.16%
 
t6 = 0.1896; P 
= 0.8571 
N
2 (30’): 
54.22±3.97%
 
N
2 (10’-30’): 
16.71±2.33%
 
acs-22 (30’): 
44.59±3.00%
 
acs-22 (10’-30’): 
6.23±1.61%
 
t6 = 6.565; P 
= 0.0012 
IS not different from
 N
2; 
R
educed AFT than N
2 
C
ytosolic acyl 
C
oA Æ
 
M
itochondrial 
cpt-3(gk356297)* 
N
2 (10’): 
39.64±2.43%
 
cpt-3 (10’): 
43.93±2.50%
 
t8 = 2.095; P 
= 0.0744 
N
2 (30’): 
59.11±3.82%
 
N
2 (10’-30’): 
cpt-3 (30’): 
56.10±2.15%
 
cpt-3 (10’-30’): 
t8 = 1.751; P 
= 0.1234 
IS not different from
 N
2; AFT 
not different from
 N
2 
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acyl C
oA
 
(Transport) 
19.47±4.07%
 
12.17±2.30%
 
cpt-4(gk818803)* 
N
2 (10’): 
39.64±2.43%
 
cpt-4 (10’): 
37.97±2.96%
 
t8 =  0.5597; 
P = 0.5931 
N
2 (30’): 
59.11±3.82%
 
N
2 (10’-30’): 
19.47±4.07%
 
cpt-4 (30’): 
49.66±5.29%
 
cpt-4 (10’-30’): 
11.70±3.16%
 
t8 = 1.348; P 
= 0.2211 
IS not different from
 N
2; AFT 
not different from
 N
2 
cpt-6(gk594576) 
N
2 (10’): 
33.71±0.92%
 
cpt-6 (10’): 
33.71±4.44%
 
t4 = 0.0010; P 
= 0.9992 
N
2 (30’): 
50.85±1.42%
 
N
2 (10’-30’): 
17.15±0.89%
 
cpt-6 (30’): 
48.94±2.45%
 
cpt-6 (10’-30’): 
15.23±2.11%
 
t4 = 1.446; P 
= 0.2440 
IS not different from
 N
2; AFT 
not different from
 N
2 
Acyl C
oA Æ
 
Trans-2-enoyl 
C
oA 
(FAD
Æ
FAD
H
2 ) 
acdh-1(ok1514) 
N
2 (10’): 
31.15%
±1.38
%
 
acdh-1 (10’): 
42.17±3.03%
 
t5 = 2.857; P 
= 0.0461 
N
2 (30’): 
48.12±1.40%
 
N
2 (10’-30’): 
16.96±1.44%
 
acdh-1 (30’): 
55.29±1.14%
 
acdh-1 (10’-30’): 
13.12±2.06%
 
t5 = 2.101; P 
= 0.1036 
Less sensitive than N
2; AFT 
not different from
 N
2 
acdh-2(gk143151) 
N
2 (10’): 
43.85±4.74%
 
acdh-2 (10’): 
43.80±3.85%
 
t5 = 0.008874; 
P = 0.9933 
N
2 (30’): 
62.70±4.28%
 
N
2 (10’-30’): 
18.86±1.41%
 
acdh-2 (30’): 
49.46±4.18%
 
acdh-2 (10’-30’): 
5.66±0.54%
 
t5 = 8.252; P 
= 0.0012 
IS not different from
 N
2; 
R
educed AFT than N
2 
acdh-5(gk907299) 
N
2 (10’): 
35.31±1.23%
 
acdh-5 (10’): 
36.08±1.53%
 
t6 = 0.3125; P 
= 0.7673 
N
2 (30’): 
52.20±1.58%
 
N
2 (10’-30’): 
16.89±0.70%
 
acdh-5 (30’): 
51.88±2.35%
 
acdh-5 (10’-30’): 
15.80±1.18%
 
t6 = 0.6510; P 
= 0.5438 
IS not different from
 N
2; AFT 
not different from
 N
2 
acdh-6(gk886629) 
N
2 (10’): 
35.31±1.23%
 
acdh-6 (10’): 
41.53±2.01%
 
t6 = 2.152; P 
= 0.0840 
N
2 (30’): 
52.20±1.58%
 
N
2 (10’-30’): 
16.89±0.70%
 
acdh-6 (30’): 
57.13±1.91%
 
acdh-6 (10’-30’): 
15.60±0.42%
 
t6 = 2.132; P 
= 0.0862 
IS not different from
 N
2; AFT 
not different from
 N
2 
acdh-7(gk556025) 
N
2 (10’): 
31.15%
±1.38
%
 
acdh-7 (10’): 
45.37±3.46%
 
t5 = 3.345; P 
= 0.0287 
N
2 (30’): 
48.12±1.40%
 
N
2 (10’-30’): 
16.96±1.44%
 
acdh-7 (30’): 
53.97±1.38%
 
acdh-7 (10’-30’): 
8.59±2.47%
 
t5 = 3.090; P 
= 0.0366 
Less sensitive than N
2; 
R
educed AFT than N
2 
acdh-11(gk753061) 
N
2 (10’): 
35.31±1.23%
 
acdh-11 (10’): 
39.24±1.43%
 
t6 = 1.818; P 
= 0.1287 
N
2 (30’): 
52.20±1.58%
 
 N
2 (10’-30’): 
16.89±0.70%
 
acdh-11 (30’): 
59.68±2.33%
 
acdh-11 (10’-
30’): 
20.44±1.71%
 
t6 = 1.593; P 
= 0.1720 
IS not different from
 N
2; AFT 
not different from
 N
2 
F54D
5.7(gk936057) 
N
2 (10’): 
F54D
5.7 (10’): 
t4 = 1.429; P 
N
2 (30’): 
F54D
5.7 (30’): 
t4 = 1.050; P 
IS not different from
 N
2; AFT 
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33.71±0.92%
 
47.75±10.01%
 
= 0.2483 
50.85±1.42%
 
N
2 (10’-30’): 
17.15±0.89%
 
55.68±2.18%
 
F54D
5.7 (10’-
30’): 
7.93±9.61%
 
= 0.3070 
not different from
 N
2 
Trans-2-enoyl 
C
oA Æ
 3-
hydroxy acyl 
C
oA
 
ech-1.2(gk527451)* 
N
2 (10’): 
39.64±2.43%
 
ech-1.2 (10’): 
39.30±1.05%
 
t8 = 0.1110; P 
= 0.9147 
N
2 (30’): 
59.11±3.82%
 
N
2 (10’-30’): 
19.47±4.07%
 
ech-1.2 (30’): 
46.95±2.182%
 
ech-1.2 (10’-
30’): 
7.650±1.86%
 
t8 = 3.077; P 
= 0.0179 
IS not different from
 N
2; 
R
educed AFT than N
2 
3-hydroxy acyl 
C
oA Æ
 3-keto 
acyl C
oA
 
(N
AD
+Æ
N
AD
H
) 
hacd-1(ok2776) 
N
2 (10’): 
37.52±3.28%
 
hacd-1 (10’): 
36.23±2.15%
 
t6 = 0.3159; P 
= 0.7648 
N
2 (30’): 
54.22±3.97%
 
N
2 (10’-30’): 
16.71±2.33%
 
hacd-1  (30’): 
49.35±1.70%
 
hacd-1(10’-30’): 
13.12±1.46%
 
t6 = 2.007; P 
= 0.1010 
IS not different from
 N
2; AFT 
not different from
 N
2 
3 keto acyl 
C
oA Æ
 Acetyl 
C
oA (+ 
shortened fatty 
acyl C
oA) 
T02G
5.4(ok3160) 
N
2 (10’): 
31.15%
±1.38
%
 
T02G
5.4 (10’): 
40.26±1.86%
 
t5 = 3.472; P 
= 0.0255 
N
2 (30’): 
48.12±1.40%
 
N
2 (10’-30’): 
16.96±1.44%
 
T02G
5.4 (30’): 
62.17±3.42%
 
T02G
5.4 (10’-
30’): 
21.91±3.42%
 
t5 = 1.279; P 
=  0.2701 
Less sensitive than N
2; AFT 
not different from
 N
2 
T02G
5.7(ok3574) 
N
2 (10’): 
33.71±0.92%
 
T02G
5.7 (10’): 
37.39±2.24%
 
t4 = 1.926; P 
= 0.1498 
N
2 (30’): 
50.85±1.42%
 
N
2 (10’-30’): 
17.15±0.89%
 
T02G
5.7 (30’): 
55.56±2.57%
 
T02G
5.7 (10’-
30’): 
18.17±1.57%
 
t4 = 0.4682; P 
= 0.6715 
IS not different from
 N
2; AFT 
not different from
 N
2 
acaa-2(ok1978) 
N
2 (10’): 
40.61±2.75%
 
acaa-2 
(10’):46.73±2.
21%
 
t6 = 2.010; P 
= 0.1006 
N
2 (30’): 
53.07±1.99%
 
N
2 (10’-30’): 
12.46±2.33%
 
acaa-2  (30’): 
54.37±1.29%
 
acaa-2 (10’-30’): 
7.64±1.83%
 
t6 = 2.576; P 
= 0.0496 
Less sensitive than N
2; AFT 
not different from
 N
2 
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Table 10. Ethanol response phenotypes of 6x backcrossed lf m
utants and R
N
Ai knockdow
n strains in m
itochondrial beta-oxidation pathw
ay in C
. elegans. The initial sensitivity 
and AFT values in this table are the relative speeds of the w
orm
s at the 10 m
inute and 30 m
inute tim
e points respectively. The (10’-30’) value for each strain represents the 
difference in relative speeds betw
een the 10 m
inute and 30 m
inute tim
e points, w
hich is a m
easure of the degree of recovery. (N
ote: For all the 6x backcrossed m
utants, the N
2s 
used as W
T for the behavioral assays are different from
 the N
2s used for the backcrossing. In the lab, it is standard practice to thaw
 out and use a new
 stock of N
2 w
orm
s once a 
year or every few
 m
onths since it is possible that the N
2 strain being m
aintained in the lab accum
ulates genetic m
utations over tim
e and is no longer ‘W
T’). 
Step catalyzed  
G
enotype 
Initial Sensitivity (IS) 
A
cute Functional Tolerance (A
FT) 
Ethanol response 
phenotypes 
W
T 
M
utant 
Significance 
W
T 
M
utant 
Significance 
Fatty acid Æ
 
Fatty acyl C
oA 
(ATPÆ
AM
P) 
acs-3(gk826522) 
N
2 (10’): 
34.81±2.17%
 
acs-3 (10’): 
32.18±2.65%
 
t6 = 0.9188; P = 
0.4003 
N
2 (30’): 
47.03±1.96%
 
N
2 (10’-30’): 
12.22±1.45%
 
acs-3 (30’): 
33.51±2.97%
 
acs-3 (10’-30’): 
1.33±1.23%
 
t6 = 11.32; P < 
0.0001 
IS not different from
 N
2; N
o 
developm
ent of AFT 
acs-4(ok2872) 
N
2 (10’): 
35.04±2.03%
 
acs-4 (10’): 
35.60±5.49%
 
t6 = 0.1438; P = 
0.8913 
N
2 (30’): 
47.30±2.14%
 
N
2 (10’-30’): 
12.27±1.06%
 
acs-4 (30’): 
50.81±5.27%
 
acs-4 (10’-30’): 
15.21±3.76%
 
t6 = 0.8301; P = 
0.4443 
IS not different from
 N
2; 
AFT not different from
 N
2 
acs-5(ok2668) 
N
2 (10’): 
30.75±2.61%
 
acs-5 (10’): 
16.03±1.99%
 
t6 = 5.336; P = 
0.0031 
N
2 (30’): 
45.27±2.24%
 
N
2 (10’-30’): 
14.53±1.18%
 
acs-5 (30’): 
19.23±1.50%
 
acs-5 (10’-30’): 
3.21±0.83%
 
t6 = 10.34; P = 
0.0001 
M
ore sensitive than N
2; 
R
educed developm
ent of 
AFT 
acs-13(ok2861) 
N
2 (10’): 
30.75±2.61%
 
acs-13 (10’): 
37.88±4.24%
 
t6 = 1.214; P = 
0.2788 
N
2 (30’): 
45.27±2.24%
 
N
2 (10’-30’): 
14.53±1.18%
 
acs-13 (30’): 
66.50±23.73%
 
acs-13 (10’-30’): 
28.62±19.93%
 
t6 = 0.7020; P = 
0.5140 
IS not different from
 N
2; 
AFT not different from
 N
2 
acs-22(gk364606) 
N
2 (10’): 
30.75±2.61%
 
acs-22 (10’): 
38.47±3.45%
 
t6 = 1.707; P = 
0.1486 
N
2 (30’): 
45.27±2.24%
 
N
2 (10’-30’): 
14.53±1.18%
 
acs-22 (30’): 
47.11±3.12%
 
acs-22 (10’-30’): 
8.64±2.62%
 
t6 = 1.937; P = 
0.1104 
IS not different from
 N
2; 
AFT not different from
 N
2 
C
ytosolic acyl 
C
oA Æ
 
M
itochondrial 
acyl C
oA
 
(Transport) 
cpt-3(gk356297) 
N
2 (10’): 
34.77±1.80%
 
cpt-3 (10’): 
38.50±3.44%
 
t6 = 1.369; P = 
0.2293 
N
2 (30’): 
45.15±3.15%
 
N
2 (10’-30’): 
10.38±1.90 
cpt-3 (30’): 
47.32±2.99%
 
cpt-3 (10’-30’): 
8.817±1.698%
 
t6 = 1.074; P = 
0.3319 
IS not different from
 N
2; 
AFT not different from
 N
2 
cpt-4(gk818803) 
N
2 (10’): 
cpt-4 (10’): 
t6 = 0.1537; P = 
N
2 (30’): 
cpt-4 (30’): 
t6 = 3.777; P = 
IS not different from
 N
2; 
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36.74±2.46%
 
37.14±0.50%
 
0.8838 
47.65±2.08%
 
N
2 (10’-30’): 
10.91±0.76%
 
54.32±0.87%
 
cpt-4 (10’-30’): 
17.18±1.01%
 
0.0129 
H
igher developm
ent of AFT 
than N
2 
W
03F9.4 (R
N
A
i) 
L4440 (10’): 
31.99±2.41%
 
W
03F9.4 
(10’): 
31.25±2.71%
 
t8 = 0.2630; P = 
0.8002 
L4440 (30’): 
42.83±2.09%
 
L4440 (10’-
30’): 
10.84±2.09%
 
W
03F9.4 (30’): 
45.18±3.42%
 
W
03F9.4 (10’-
30’): 
13.92±2.51%
 
t8 = 1.370; P = 
0.2130 
IS not different from
 L4440; 
AFT not different from
 
L4440 
Acyl C
oA Æ
 
Trans-2-enoyl 
C
oA 
(FAD
Æ
FAD
H
2 ) 
acdh-1(ok1514) 
N
2 (10’): 
32.31±2.22%
 
acdh-1 (10’): 
51.05±3.62%
 
t6 = 3.945; P = 
0.0109 
N
2 (30’): 
46.80±2.27%
 
N
2 (10’-30’): 
14.10±0.87%
 
acdh-1 (30’): 
59.29±2.13%
 
acdh-1 (10’-30’): 
8.24±3.65%
 
t6 = 2.222; P = 
0.0770 
Less sensitive than N
2; 
AFT not different from
 N
2 
acdh-2(gk143151) 
N
2 (10’): 
32.31±2.22%
 
acdh-2 (10’): 
45.30±1.52%
 
t6 = 4.076; P = 
0.0096 
N
2 (30’): 
46.80±2.27%
 
N
2 (10’-30’): 
14.10±0.87%
 
acdh-2 (30’): 
53.32±2.78%
 
acdh-2 (10’-30’): 
8.02±2.89%
 
t6 = 2.525; P = 
0.0529 
IS not different from
 N
2; 
R
educed AFT than N
2 
acdh-4 (R
N
A
i) 
L4440 (10’): 
28.54±1.69%
 
acdh-4 (10’): 
33.90±4.36%
 
t8 = 1.650; P = 
0.1428 
L4440 (30’): 
44.09±2.11%
 
L4440 (10’-
30’): 
15.56±1.38%
 
acdh-4 (30’): 
48.66±4.91%
 
acdh-4 (10’-30’): 
14.76±2.726%
 
t8 = 0.3117; P = 
0.7644 
IS not different from
 L4440; 
AFT not different from
 
L4440 
acdh-7(gk556025) 
N
2 (10’): 
32.31±2.22%
 
acdh-7 (10’): 
38.92±4.05%
 
t6 = 1.573; P = 
0.1766 
N
2 (30’): 
46.80±2.27%
 
N
2 (10’-30’): 
14.10±0.87%
 
acdh-7 (30’): 
43.98±3.31%
 
acdh-7 (10’-30’): 
5.065±2.83%
 
t6 = 3.510; P = 
0.0171 
IS not different from
 N
2; 
R
educed AFT than N
2 
acdh-8 (R
N
A
i) 
L4440 (10’): 
28.46±1.93 
acdh-8 (10’): 
30.03±2.46%
 
t8 = 1.357; P =  
0.2169 
L4440 (30’): 
44.35±2.15%
 
L4440 (10’-
30’): 
15.89±1.34%
 
acdh-8 (30’): 
46.53±2.78%
 
acdh-8 (10’-30’): 
16.50±1.46%
 
t6 = 0.3235; P = 
0.7557 
IS not different from
 L4440; 
AFT not different from
 
L4440 
acdh-10 (R
N
A
i) 
L4440 (10’): 
29.19±1.76%
 
acdh-10 
(10’): 
38.72±1.89%
 
t8 = 6.182; P = 
0.0005 
L4440 (30’): 
43.94±2.14%
 
L4440 (10’-
30’): 
14.75±1.22%
 
acdh-10 (30’): 
50.20±2.14%
 
acdh-10 (10’-
30’): 
11.48±1.00%
 
t8 = 2.788; P = 
0.027 
Less sensitive than L4440; 
R
educed AFT than L4440 
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acdh-12 (R
N
A
i) 
L4440 (10’): 
31.05±2.69%
 
acdh-12 
(10’): 
39.10±2.34%
 
t8 = 3.039; P = 
0.0189 
L4440 (30’): 
44.07±2.47%
 
L4440 R
ec 
(10’-30’): 
13.02±1.19%
 
acdh-12 (30’): 
54.16±2.94%
 
acdh-12 R
ec 
(10’-30’): 
15.07±2.41%
 
t8 = 0.7977; P = 
0.4512 
Less sensitive than L4440; 
AFT not different from
 
L4440 
Trans-2-enoyl 
C
oA Æ
 3-hydroxy 
acyl C
oA
 
ech-
1.2(gk527451) 
N
2 (10’): 
36.74±2.46%
 
ech-1.2 (10’): 
43.60±3.69%
 
t6 = 1.457; P = 
0.2048 
N
2 (30’): 
47.65±2.08%
 
N
2 (10’-30’): 
10.91±0.76%
 
ech-1.2 (30’): 
56.02±4.38%
 
ech-1.2 (10’-
30’): 
3.63±1.56%
 
t6 = 5.824; P = 
0.0021 
IS not different from
 N
2; 
R
educed AFT than N
2 
ech-1.1 (R
N
A
i) 
L4440 (10’): 
31.05±2.69%
 
ech-1.1 (10’): 
36.90±4.23%
 
t8 = 1.133; P = 
0.2946 
L4440 (30’): 
44.07±2.47%
 
L4440 (10’-
30’): 
13.02±1.19%
 
ech-1.1 (30’): 
52.39±4.85%
 
ech-1.1 (10’-
30’): 
15.49±3.59%
 
t8 = 0.5919; P = 
0.5726 
IS not different from
 L4440; 
AFT not different from
 
L4440 
3 keto acyl C
oA 
Æ
 Acetyl C
oA (+ 
shortened fatty 
acyl C
oA) 
T02G
5.4(ok3160) 
N
2 (10’): 
34.77±1.80%
 
T02G
5.4 
(10’): 
43.60±2.44%
 
t6 = 2.427; P = 
0.0596 
N
2 (30’): 
45.15±3.15%
 
N
2 (10’-30’): 
10.38±1.90%
 
T02G
5.4 (30’): 
55.79±4.36%
 
T02G
5.4 (10’-
30’): 
12.19±2.78%
 
t6 = 0.5017; P = 
0.6372 
IS not different from
 N
2; 
AFT not different from
 N
2 
acaa-2(ok1978) 
N
2 (10’): 
34.77±1.80%
 
acaa-2 (10’): 
39.09±2.17%
 
t6 = 4.066; P = 
0.0097 
N
2 (30’): 
45.15±3.15%
 
N
2 (10’-30’): 
10.38±1.90%
 
acaa-2  (30’): 
52.28±2.91%
 
acaa-2 (10’-30’): 
13.19±1.89%
 
t6 = 0.9148; P = 
0.4023 
Less sensitive than N
2; 
AFT not different from
 N
2 
 
B
0303.3 (R
N
A
i) 
L4440 (10’): 
30.24±3.03%
 
B
0303.3 
(10’): 
29.75±2.86%
 
t6 = 0.2232; P = 
0.8298 
L4440 (30’): 
44.74±2.50%
 
L4440 (10’-
30’): 
14.51±1.51%
 
B
0303.3 (30’): 
44.48±3.54%
 
B
0303.3 (10’-
30’): 
14.74±1.82%
 
t6 = 0.1214; P = 
0.9067 
IS not different from
 L4440; 
AFT not different from
 
L4440 
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3.3  Ethanol affects mitochondrial beta-oxidation 
A search on NCBI (PubMed Central) for ‘mitochondrial beta-oxidation AND 
ethanol’ gives 13325 results, 8226 of them published in the last five years. A 
majority of studies examines the effects of alcohol/ethanol on mitochondrial 
function, particularly in hepatocytes, since the liver is the primary site for 
alcohol metabolism. Several research groups have also dissected the 
molecular mechanisms underlying mitochondrial dysfunction in 
neurodegenerative diseases like Alzheimer’s disease, Parkinson’s disease, 
Huntington’s disease and alcoholic dementia (Akbar et al., 2016; Srivastava et 
al., 2010). 
 
Ethanol has been found to cause mitochondrial dysfunction, damage to 
mitochondrial DNA and inhibition of mitochondrial beta-oxidation of FA. 
Ethanol also affects oxidative phosphorylation and electron transport chain 
processes in the mitochondria. The focus has been on the role of 
mitochondria in progression of alcoholic liver diseases (ALD) and its 
usefulness as a therapeutic target for ALD (Apostolova & Victor, 2015; King et 
al., 2016). Mitophagy has been found to prevent cell death in alcohol-induced 
liver injury by removing damaged mitochondria that are unable to perform 
beta-oxidation of FA (Ding et al., 2011).   
 
Andringa et al., (2010) used Male Sprague-Dawley rats to analyze the effect 
of ethanol on the liver mitochondria proteome. They pair fed these rats a 
control diet and an ethanol-containing diet for at least 31 days and then 
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performed a series of experiments to look at how mitochondrial proteins 
respond to alcohol exposure. They extracted and separated mitochondrial 
proteins by isoelectric focusing followed by gel electrophoresis. The 2D gel 
image analysis of these mitochondrial proteins showed that 30 of the 76 
proteins examined were altered in abundance in response to ethanol. Using 
mass-spectrometry analysis, they identified these proteins and grouped them 
into four functional classes, one of them being mitochondrial-beta-oxidation. 
They determined that several enzymes involved in mitochondrial beta-
oxidation, long-chain ACDH, ECH and long-chain HADH, were significantly 
decreased in the alcohol-fed rats compared to controls.  
 
To assess the effect of ethanol on mitochondrial outer membrane (MOM) 
permeability Holmuhamedov & Lemasters (2009) incubated isolated rat 
hepatocytes with ethanol and exposed the cells to a low concentration of 
digitonin, which selectively permeabilizes the plasma membrane to allow entry 
of adenine nucleotides and exogenous respiratory substrates like succinate. 
They measured oxygen consumption and adenylate kinase activity before and 
after digitonin treatment and found that ethanol pretreatment decreased 
succinate-supported respiration. Also, MOM permeabilization with high 
digitonin overcame the effects of ethanol and restored respiration and 
adenylate kinase activity. Moreover, high digitonin treatment of untreated 
hepatocytes did not change the rate of succinate-supported respiration or 
adenylate kinase activity. These results suggested that MOM permeability to 
hydrophilic metabolites decreases after ethanol treatment. Since voltage 
dependent anion channel (VDAC) is the only channel known to allow 
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hydrophilic metabolites to cross the outer membrane of the mitochondria in 
normal viable cells, they hypothesized that ethanol-induced decrease of 
mitochondrial outer membrane permeability could be through inhibition of 
VDAC. 
 
 In another study performed in cultured rat hepatocytes, Bailey et al., (1999)  
found that ethanol decreased mitochondrial FA oxidation and production of 
ATP. They hypothesized that this could be through the inhibition of the 
conductance of VDAC in the mitochondrial outer membrane since VDAC is 
essential for maintaining the permeability of outer mitochondrial membrane to 
molecules that are necessary for beta-oxidation such as ATP, ADP and fatty 
acyl CoA. Bailey and Cunningham (1998) found that ethanol also altered 
cellular energy balance, which plays a role in beta-oxidation. Specifically, they 
found that in isolated hepatocytes, acute ethanol exposure increased the 
cellular NADH/NAD+ ratio, which would be predicted to inhibit mitochondrial 
beta-oxidation, as it is an allosteric regulator of the pathway. They 
hypothesized that this increase could be due to increase in production of 
mitochondrial reactive oxygen species (ROS) (Bailey et al., 1999). Thus, it is 
clear that ethanol affects various biological pathways occurring in the 
mitochondria, and that mitochondrial beta-oxidation of FA is one of them. 
 
While the effects of ethanol on mitochondrial function and beta-oxidation of 
FA has been well studied, there has not been much research on how the 
various components of beta-oxidation in mitochondria affect ethanol 
metabolism and its effects on the organism. For the purpose of this project, 
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we were particularly interested in examining whether mitochondrial beta-
oxidation has a role in neuronal responses to ethanol exposure. We tested 
genes at every step of mitochondrial beta-oxidation. Our results from 
behavioral assays of lf mutants and RNAi knockdown strains indicate that 
there is certainly more than one step or enzyme or reaction component of the 
pathway that is involved in mediating this effect.  
 
It is important to keep in mind while interpreting this data that (1) a majority of 
the enzymes catalyzing this pathway exhibit chain-length specificity (2) there 
are several aspects of beta-oxidation that have diverse physiological 
functions, like free fatty acids (FFA, the first substrate of beta-oxidation), 
energy transfers that occur during beta-oxidation, and intermediate products 
like fatty acyl CoA. Long chain FFA increase mitochondrial permeability, 
uncouple oxidative phosphorylation and inhibit ATP synthesis while non-
esterified FA are metabolized into diacyl glycerol (DAG) (Wojtczak & 
Schonfeld, 1993). Acyl CoA derivatives inhibit tricarboxylic acid (TCA) cycle 
and also competitively inhibit activation of pyruvate carboxylate, which is an 
enzyme involved in gluconeogenesis. Acyl CoA also plays a role in synthesis 
of polar and neutral lipids, and TAGs. The functions of these components of 
beta-oxidation are discussed in detail in subsequent paragraphs.  
 
3.4 Acyl CoA Synthases (ACS) 
Acyl CoA synthases (ACS) catalyze the first step of mitochondrial beta-
oxidation, converting FA to fatty acyl CoA (Figure 9). We examined seven 
acs-family genes including acs-2, which was previously tested by Dr. Alaimo 
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(see Introduction) and three of the lf mutant strains showed a significantly 
different ethanol response phenotype. acs-2 displayed reduced AFT 
compared to WT but did not differ significantly in initial sensitivity. acs-3 
mutants did not develop AFT in response to ethanol, but were not significantly 
different from WT in terms of initial sensitivity. acs-5 showed reduced AFT 
development and increased sensitivity in response to ethanol compared to 
WT worms. acs-4, acs-13, acs-17 and acs-22 lf strains showed ethanol 
responses similar to WT. At the 2x backcrossed stage, acs-4, acs-13 and acs-
22 also showed a significant ethanol response phenotypes, but the 
significance of this was lost when backcrossed to 6x. This may not be 
surprising, because by backcrossing we are eliminating possible background 
mutations. So, it is possible that the phenotypes are less robust in the 6x-
backcrossed strain of certain mutants compared to their 2x-backcrossed 
strain which implies that the ethanol response phenotypes observed in the 2x-
backcrossed mutants could have been due to the effect of background 
mutations in the mutant strains. 
 
Disruption of the esterification or activation of FA to fatty acyl CoA would lead 
to an increase in the levels of FFA and decrease in acyl CoA. FFA, which are 
the first substrate in the beta-oxidation of FA, have diverse physiological 
functions. Among their functions is a role in the activation of protein kinase C 
(PKC) in different cells or organs (Boneh, 1996). PKC is a family of enzymes 
that activate or regulate other proteins by phosphorylation of hydroxyl groups 
on the serine and threonine residues of the target proteins. One member of 
this family is the PKCγ, which is solely expressed in the brain and spinal cord. 
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It is activated by Ca+2, phosphatidylserine and DAGs. PKCγ is also activated 
by unsaturated FA, with the extent of activation being proportional to the 
degree of unsaturation (Nishizuka, 1992). Studies have shown that γ-
aminobutyric acid A (GABAA) receptors in the brain of PKCγ-deficient mice do 
not respond to ethanol, and the PKCγ-deficient mice show a reduced 
sensitivity to acute ethanol (measured using righting reflex and body 
temperature). Saito & Shirai (2002) suggested that PKCγ modulates the 
sensitivity of GABAA receptors to ethanol. GABA is an inhibitory 
neurotransmitter and GABAA is a class of GABA receptors. It has been shown 
in numerous research studies that ethanol potentiated GABAA mediated 
current, which increased the action of GABA at these receptors (Davies, 
2003). Breaking down the hypothesis of Saito & Shirai, in the absence of 
PKCγ the GABAA receptors would not be potentiated by ethanol and therefore 
there would be decreased/no action of GABA at these receptors. This in turn, 
would result in decreased inhibitory action of GABA on the nervous system, 
which would explain the reduced sensitivity of PKCγ-deficient mice to acute 
ethanol. Applying these findings to the ethanol response phenotype we saw in 
some of the acs mutants (acs-3, acs-4 and acs-5 showed increased sensitivity 
to ethanol, and acs-5 showed reduced development of AFT), I hypothesize 
that lack of ACS activity in these mutants would lead to the buildup of FFA. 
This could increase activation of PKCγ, which, in turn, could lead to increased 
sensitivity to ethanol compared to the WT worms in which there is 
comparatively less amount of FFA. To test this hypothesis, we could create 
and test a double mutant of pkc-2;acs-5 (that has lf in pkc-2, which is the 
PKCγ in C. elegans and acs-5) for ethanol responses. We could then express 
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pkc-2 specifically in the neurons expressing GABAA receptors in the double 
mutants using the promoter of unc-49. The reason for creating a pkc-2(lf) 
specifically in these neurons is to make sure that the effect of pkc-2(lf) on 
ethanol response phenotypes we expect to see would not be confounded by 
potential action of PKC through other neurotransmitter receptors. If lack of 
acs-5 activity is indeed modulating sensitivity to ethanol through PKC 
activation and GABA, we would expect the sensitivity of the pkc-2;acs-5 lf 
double mutant to be lower than that of the acs-5(lf), since there is no PKC for 
the FFA to activate and therefore, no potentiation of GABA. 
 
FFA have also been found to affect neurotransmitter receptors; particularly 
neuronal nicotinic acetylcholine receptors (nAChRs) in various in vitro and in 
vivo models, but the results from these studies are conflicting (Albuquerque et 
al., 2009; Antollini & Barrantes, 2016) showed that FFAs had an inhibitory 
effect on nAChR. Ikeuchi et al., 1996 suggested that the effects of FA on 
nAChRs vary across species, possibly due to the differences in receptor 
subunit structure and composition in various organisms. They saw a 
potentiation effect of arachidonic acid (AA), a PUFA, on Torpedo nAChR 
expressed in Xenopus oocytes and treatment of chick α7 nAChR with AA 
caused a depression effect while treatment of rat α7 nAChR caused 
exclusively a potentiation effect by PKC activation.  
 
α7 nAChRs have also been extensively studied in understanding the 
mechanism of ethanol’s action on the brain. McDaid et al., 2016 tested effects 
of ethanol on α7 nAChRs using brain sections of male Sprague Dawley rats. 
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They performed electrophysiological studies to measure nAChR-mediated 
currents, on isolated sections containing laterodorsal tegmental nucleus 
(LDTg), where the α7 receptors are expressed abundantly. They found that 
pretreatment with 25mM ethanol for 10 minutes inhibited α7 nAChR currents 
significantly. Yu et al., (1996) using α7 nAChRs expressed in Xenopus 
oocytes, looked at the effect of ethanol on these receptors. Their 
electrophysiological recordings of nAChR currents using two-electrode 
voltage clamp, revealed that application of ethanol inhibited α7 nAChR 
currents in a concentration-dependent manner over a concentration range of 
5-100 mM ethanol. Studies in cultured rat cortical neurons showed that 
ethanol potentiated non-α7 nAChR- but inhibited α7 nAChR-mediated 
currents. In Xenopus oocytes, ethanol at low concentrations inhibited α7 
nAChR currents but potentiated α2β4, α4β4, α2β2, and α4β2 nAChRs at 
higher concentrations (Wu et al., 2014). Seeing that the α7 nAChR has been 
widely studied in the context of FFA and neuronal effect of ethanol, I consider 
it as an ideal candidate to pursue for future experiments. 
 
Based on the evidence discussed above, I propose a model to test if the 
effect of acs lf on ethanol responses acts through regulation of α7 nAChR by 
FFA. In C. elegans, acr-16 codes for a α7-like subunit of nAChR, which is 
orthologous to the human nAChR α7 (sharing 81.7% protein sequence 
identity). An acr-16 mutant was tested by Patraic Lichtman (a student in the 
Davies-Bettinger lab) for effects on ethanol response phenotypes and he 
found that this mutant is resistant to ethanol (decreased sensitivity compared 
to N2), which supports previous findings that ethanol could be acting through 
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inhibition of α7 nAChR. Lf mutants of acs-3, acs-4 and acs-5 showed 
increased sensitivity to ethanol. If the effect of loss of acs function on 
sensitivity is due to action of FFA on ACR, I hypothesize that, a double mutant 
of acs-5;acr-16 lf assayed on ethanol would display decreased initial 
sensitivity compared to acs-5 lf mutants. acs-5 lf would increase concentration 
of FFA, but due to lf in acr-16, the FFA would be unable to potentiate the α7-
like receptor, due to which I predict that the initial sensitivity would be 
decreased compared to the acs-5 mutant. 
 
We can see that while acs-5(lf) results in increased initial sensitivity, acs-2, 
acs-3 and acs-5 appear to be important for AFT, since worms carrying 
deletions in these genes exhibit reduced AFT relative to N2. A possible 
reason for the varying effects of different acs genes on the two ethanol 
responses phenotypes could be that each of these enzymes catalyzes 
esterification of FA for different pathways, and some of these pathways might 
affect only one of the two ethanol response components we are studying. For 
example, loss of acs-2 function affects tolerance but not sensitivity and loss of 
acs-4 affects sensitivity, not AFT. On the other hand, acs-22, acs-17 and acs-
13 lf do not have any effect on either sensitivity or AFT to ethanol. From 
studying human ACS genes, we know that each member of the ACS family 
preferentially catalyzes the esterification of specific chain lengths of FA and 
directs the FA-CoAs into different downstream processes (Figure 10). 
Therefore, it is possible that these acs-genes partition the acyl CoA into 
downstream pathways that vary in their effects on ethanol response behavior.  
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Since there has not been very extensive research conducted on worm ACS 
enzymes, we used evidence from human (cell culture studies) and mouse 
models looking at the orthologs of these worm genes to understand the 
various pathways into which acyl CoAs are partitioned by the different ACS 
genes (Table 11). 
Table 11. Human and Mouse orthologs of acs genes tested for ethanol responses. 
acs genes in C. 
elegans 
Human Ortholog Mouse Ortholog 
acs-2 ACSF2 ACSF2 
acs-4 & acs-17 ACSL3/ACS3 
ACSL4/ACS4 
ACSL3 
ACSL4 
acs-5, acs-3 & 
acs-13 
ACSL1 
ACSL5 
ACSL6 
ACSL5 
acs-22 SLC27A1 (FATP1) 
SLC27A2 (FATP2) 
 SLC27A3 (FATP3) 
SLC27A4 (FATP4) 
SLC27A5 (FATP5) 
SLC27A6 (FATP6) 
SLC27A1 (FATP1) 
SLC27A2 (FATP2) 
SLC27A4 (FATP4) 
SLC27A5 (FATP5) 
 
As briefly discussed in the Introduction, ACS enzymes catalyze the 
activation/esterification of FFA into fatty acyl CoA in an ATP-dependent 
reaction. The fatty acyl CoA produced can enter the mitochondrial matrix 
(long-chain FA-CoAs require carnitine for transport while short and medium-
chain FA-CoAs can directly enter the matrix), or can become involved in a 
variety of other biological processes including synthesis of TAGs, 
sphingolipids, phospholipids, protein acetylation and transcriptional regulation 
of gene expression (Watkins & Ellis, 2012).  
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The Coleman group has been studying ACS enzymes for several years using 
a combination of in vitro overexpression in rat cell lines and in vivo knockout 
mouse models. They have characterized the structure, tissue localization 
(Mashek et al., 2007) and physiological functions various ACS family 
members (Cooper et al., 2015). Their experiments using broad and specific 
inhibitors of ACS enzymes revealed that both ACS1, which is expressed in 
heart, liver and adipose tissues, and ACS2, a brain-specific subtype, exhibit 
broad substrate specificity and show structural similarity. ACS3 is highly 
expressed in brain and uses laurate and myristate most efficiently among the 
C8–C22 saturated FA and arachidonate and eicosapentaenoate among the 
C16–C22 unsaturated FA. ACS4 shows a preference for arachidonate and 
eicosapentaenoate (PUFAs) and C14-C22 unsaturated FA, and exhibits a low 
affinity for palmitate (Kang et al., 1997). Also, the Coleman group showed that 
specific inhibition of ACS1 and ACS4 suggested that they are involved in 
triacylglycerol synthesis and de novo synthesis of phospholipids and 
phospholipid reacylation. This also suggested that oxidation must rely on acyl-
CoA synthesized by other isoforms (Coleman et al., 2002). 
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Figure 10. Inhibitors suggest possible products of acyl-CoA produced by ACS 
isoforms. Coleman et al., (2002) used two inhibitors, Triascin C (a fungal-derived competitive 
inhibitor of ACS) and Troglitazone, a thiazolidinedione (TZD), which selectively inhibits some 
pathways catalyzed by ACS enzymes. Triascin C was found to inhibit ACS1 and ACS4, but 
not ACS5, and TZD inhibited only ACS4. Using labeled FA of different chain lengths and 
recombinant expression of specific rat ACS isoforms in E. coli expression vectors, it was 
found that Triascin C inhibited the incorporation of [3H]glycerol into phospholipid and 
triacylglycerol, in human fibroblasts and also blocked Incorporation of [14C]oleate into 
triacylglycerol in rat hepatocytes. Abbreviations: ACS, acyl-CoA synthetase; CE, cholesteryl 
ester; PL, phospholipid; TAG, triacylglycerol; TZD, thiazolidinedione. Reused with permission 
from “Do Long-Chain Acyl-CoA Synthetases Regulate Fatty Acid Entry into Synthetic Versus 
Degradative Pathways?”, by R.A. Coleman, et al., 2002,  The Journal of Nutrition, 132 (8), 
p.2123. Copyright 2002, by The American Society for Nutritional Sciences. 
 
Therefore, the ideal next step in identifying specific mechanisms through 
which these acs genes could be acting to modulate responses to ethanol, 
would be to characterize genes within each of these downstream pathways 
and test candidates that could give the most information about the role of that 
pathway in ethanol response (by choosing a gene that codes for an enzyme 
that is essential and exclusive for that particular pathway). For example, 
glycerol-3-phosphate acyl transferase (GPAT) is the enzyme catalyzing the 
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first step of phospholipids from glycerol-3-phosphate and a saturated acyl 
CoA, which forms lyophosphatidic acid. This is followed by addition of a 
second acyl CoA by acylglycerol-3-acyltransferase (AGPAT) to 
lyophosphatidic acid to form phosphatidic acid, which then is metabolized into 
DAG, TAG and other phospholipids like phosphatidyl inositol and phosphatidyl 
choline. GPAT acts in the outer mitochondrial membrane and AGPAT acts in 
the ER (Wendel et al., 2009). Using genetic mutants that block these two 
pathways that are essential for phospholipid, DAG and TAG synthesis could 
be a useful first step in narrowing down the possible mechanisms through 
which acyl CoA could be affecting ethanol response phenotypes. In 
C. elegans, acl-6 codes for the mitochondrial GPAT and acl-4 and acl-5 code 
for the GPAT expressed in the ER. Testing the lf mutants of these genes for 
ethanol responses would help in determining if phospholipid synthesis and its 
downstream pathways affect ethanol response phenotypes. Also, testing the 
levels of FFA in these acs mutants would be a simple first step in determining 
if the effects of ACS lf on ethanol response phenotypes is due to an increase 
in levels of FFA. This would allow us to also examine the specific chain-length 
of FFA that is increased in these mutants, which could reveal the substrate-
specificity of the different acs genes in C. elegans. 
 
3.5 Carnitine Palmitoyl Transferases (CPT) 
The carnitine shuttle transports long chain acyl CoA across the mitochondrial 
membrane, by reversibly converting it to acyl carnitine. cpt-1 codes for CPTI 
which is localized in the outer mitochondrial membrane and conjugates 
activated long-chain FA with carnitine to form acyl carnitine, which is then 
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transported across the inner plasma membrane by Carnitine-acylcarnitine 
translocase (CACT). CPTII (gene, cpt-2) converts the acyl carnitine to fatty 
acyl CoA by the addition of coenzyme A. CPTI in mammals has three tissue-
specific isoforms, CPT1A which is expressed in the liver, CPTIB, expressed in 
the muscle, and CPTIC, which is expressed in the brain (Sharma & Black, 
2009). I tested C. elegans mutants of three (cpt-3, cpt-4 and cpt-6) of the six 
known cpt genes, and Dr. Alaimo, as part of his thesis project, performed 
RNAi for two of the other cpt genes (cpt-2 and cpt-5).  
 
The 2x backcrossed cpt-6 mutant strain, and the cpt-2 and cpt-5 RNAi-fed 
worms were not significantly different from the WT worms in their ethanol 
responses. Though behavioral assays of the 2x backcrossed cpt-3 and cpt-4 lf 
mutants did not show a statistically significant difference in initial sensitivity 
and AFT compared to WT, considering the high error on these assays and the 
trend towards reduced AFT seen in both mutants, we decided to backcross 
these to 6x and test them again. The 6x backcrossed mutant of cpt-3 did not 
show a significant difference in its ethanol responses compared to WT worms 
and the 6x backcrossed mutant of cpt-4 had higher AFT development 
compared to WT, but did not differ significantly from WT in terms of initial 
sensitivity. 
 
Lack of CPT function would disrupt the entry of long-chain acyl CoA into the 
matrix thus halting mitochondrial beta-oxidation of these FA, and also leading 
to a buildup of cytosolic acyl CoA that cannot be transported into the 
mitochondria. Based on the behavioral assay results from the lf mutants and 
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Dr. Alaimo’s data, it appears that only lf of cpt-4 affects ethanol responses. 
This implies that either cpt-4 function in mitochondrial beta-oxidation is 
unique, and not compensated for by other cpt genes or that cpt-4 has some 
other function (apart from transport of fatty acyl CoA into the mitochondria) 
that has an effect on AFT in response to ethanol.  
 
I also performed RNAi for W03F9.4, a C. elegans gene predicted to have 
carnitine O-octanoyltransferase function, which in humans has been shown to 
be involved in transport of long and medium-chain acyl CoA from the 
peroxisomes to mitochondria and cytosol. This gene was included for testing 
due to its orthology to CPT1A (from DIOPT), but the W03F9.4 RNAi-fed 
worms did not show a significantly different ethanol responses compared to 
L4440. In case of RNAi, a positive result (significant phenotype) observed is 
considered as evidence for the importance of that gene in modulating the 
phenotype. However, failure to observe a phenotype (like in the case of 
RNAi–mediated knockdown of W03F9.4, cpt-2 and cpt-5) does not mean that 
those genes do not have an effect on ethanol responses, and the results of 
this need to be confirmed with lf mutants. Also, it would be interesting to see if 
cpt-1, the cpt gene in C. elegans that we did not assay, could play a role in 
regulating ethanol responses. 
 
3.6 Acyl CoA dehydrogenases (ACDH) 
ACDHs catalyze the first dehydrogenation step in beta-oxidation within the 
mitochondria, converting acyl CoA to trans-2-enoyl CoA and require FAD as a 
co-factor to perform their function. As discussed in the Introduction, human 
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ACADs in the mitochondria are grouped into short, medium and long-chain 
enzymes based on their substrate chain-length specificity. 
 
I tested 10 of the 12 acdh genes for a role in ethanol responses, using lf 
mutants for six acdh genes (acdh-1, acdh-2, acdh-5, acdh-6, acdh-7 and 
acdh-11) and RNAi-mediated knockdown for the other four (acdh-4, acdh-8, 
acdh-10 and acdh-12). Five of these ten genes showed significantly different 
ethanol responses phenotype compared to WT. Grouping these genes by 
their substrate-specificity, we see that, lf in the two short-chain acdh genes, 
acdh-1 and acdh-2 leads to ethanol resistance, but has no effect on AFT. Two 
of the three medium-chain acdh genes, acdh-7 and acdh-10, have reduced 
AFT, and acdh-10 also exhibits a decrease in sensitivity. The other medium-
chain enzyme, acdh-8, did not appear to have an effect on ethanol responses 
based on RNAi knockdown. All three of the long-chain specific ACDH enzyme 
genes, acdh-5, acdh-6 and acdh-11 did not show difference in their ethanol 
responses, while RNAi of acdh-12, that catalyzes dehydrogenation of very 
long-chain acyl CoAs, showed decreased sensitivity but no effect on AFT.  
 
Lf of ACDH would be predicted to prevent the formation of trans-2-enoyl CoA 
and result in accumulation of acyl CoA inside the mitochondria. This would 
also be predicted to alter the cellular ratio of FAD/FADH2, and there would be 
decreased entry of FADH2 into the ETC. This would disrupt the energy 
production from ETC in the form of ATP (FADH2 provides energy required for 
the synthesis of 2 ATP molecules through the ETC), ultimately resulting in 
decreased ATP production. There is not much information available on this 
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class of enzymes apart from their role in mitochondrial beta-oxidation and 
associated metabolic diseases, hence it is difficult to hypothesize about which 
of the above events could most likely contribute to the ethanol response 
phenotypes being observed in these mutants. The FAD/FADH2 ratio in these 
acdh mutants can be determined using fluorescence based assays. 
Comparing the ratio of FAD/FADH2 between the acdh mutants displaying 
altered ethanol response phenotypes and the ones displaying WT-like ethanol 
responses could help us determine if this ratio is important in altering neuronal 
responses to ethanol in C. elegans. If the FAD/FADH2 ratio correlates with the 
ethanol response phenotypes in the acdh mutants, the next step would be to 
examine the effect of the ETC on neuronal responses to ethanol since the 
FADH2 molecules (released during this reaction) enter the ETC to produce 
energy. 
 
3.7 Enoyl CoA Hydratases (ECH) 
ECH catalyze the hydration of trans-2-enoyl CoA to form 3-hydroxy acyl CoA 
and in higher eukaryotes, the activity of ECH and the other two downstream 
enzymes HACD and KAT are carried out by a MTP for oxidation of long-chain 
FA. The C. elegans ech family of genes consists of seven members, of which 
I have tested three (ech-1.1 using RNAi and ech-1.2 and ech-7 using lf 
mutants) and Dr. Alaimo tested the roles of four genes using RNAi (ech-1.2, 
ech-2, ech-4 and ech-6). I tested a lf mutant of ech-1.2, though Dr. Alaimo 
had performed an RNAi knockdown of this gene and showed that it did not 
have a significant effect on ethanol response phenotypes, since the lack of 
phenotype seen by RNAi is not reliable. In C. elegans, to determine the 
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effectiveness of RNAi, (Kamath et al., 2003) compared the RNAi phenotypes 
to phenotypes of know lf mutants and found that while the false positive rate 
was <1%, the rate of false negatives was substantially higher, 30%. Possible 
reasons for this high false negative rate could be variation in RNAi feeding 
protocol, certain genes are more sensitive to RNAi feeding than others and 
that some phenotypes exhibit low penetrance, meaning that the phenotype is 
expressed in some worms in a population and not in others (Kamath et al., 
2001). Therefore, such cases where we see no significant phenotype through 
RNAi feeding need to be confirmed with a lf mutant, when possible. Another 
way to confirm this would be to use overexpression of the enzyme to see if 
that exhibits a significant ethanol response behavior. The effectiveness of 
RNAi could be determined by qRT-PCR, before contemplating the use of lf or 
gf mutants.  
 
RNAi knockdown of ech-1.1 and ech-1.2 (performed by Dr. Alaimo) did not 
show significantly different ethanol responses compared to WT, but the 2x 
backcrossed lf mutant of ech-1.2 showed a significantly reduced AFT, so we 
backcrossed this mutant 6x and confirmed this phenotype. Also lf in ech-7 
caused reduced AFT. On the other hand, RNAi knockdown of ech-6 showed 
an increase in AFT. The initial sensitivity in all these three cases was similar 
to WT.  
 
Loss of ECH function would result in trans-2-enoyl CoA accumulation and a 
halt in the progression of mitochondrial beta-oxidation. In C. elegans, ech-1.1 
and ech-1.2 are the two orthologs of HADHA, the alpha-subunit of the 
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mitochondrial trifunctional protein, which exhibits ECH/long-chain HADH 
activity. ech-6 and ech-7 are orthologous to the ECHS1, which catalyzes 
hydration of short-chain FA. This suggests that a disruption of ECH enzymes 
that act on both long-chain and short-chain FA has an effect on ethanol 
responses. All three of the ech genes appear to affect only the AFT 
component of ethanol response and not the initial sensitivity. Also, the change 
in AFT in ech-6 and ech-7 lf are in opposite directions, which is probably not 
due to chain-length specificity since both of these are orthologs of the short-
chain ECH. While ech-6 localizes to the mitochondria, the information on 
subcellular or tissue-specific expression of ech-7 in C. elegans is not 
available. One possibility is that the expression pattern could explain the 
difference in direction of AFT between these two strains.  
 
3.8 Hydroxy acyl CoA dehydrogenases (HACD/HADH)  
These are oxidoreductases, which catalyze the oxidation of 3-hydroxy acyl 
CoA to 3-keto acyl CoA and this reaction is coupled with the reduction of 
NAD+ to NADH. I examined a lf mutant of hacd-1, the only ortholog of the 
human HADH in C. elegans, and found that there was no effect on ethanol 
responses due to loss of hacd-1 function. Since ech-1.2 and ech-1.1 are 
orthologs of the MTP, they are also predicted to be involved in this step of the 
pathway. 
 
Among the consequences of disrupting of this step in beta-oxidation would be 
predicted to be an increase in the concentration of 3-hydroxy acyl CoA and 
alteration in the ratio of NADH/NAD+. This ratio has shown to be involved in 
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the allosteric regulation of beta-oxidation, i.e., increase in the NADH/NAD+ 
ratio has shown to inhibit beta-oxidation. Three independent studies (Grunnet 
& Kondrup, 1986; Lieber, 1994; Reitz, 1979) showed that ethanol metabolism 
(into acetate and acetaldehyde) alters the NADH/NAD+ ratio, which inhibits 
HADH activity and thus decreases the level of mitochondrial beta-oxidation. 
Adachi & Ishii (2002) in their study of rat-cultured hepatocytes showed that 
acute ethanol exposure increased superoxide generation in the mitochondria, 
which they hypothesized was due to an increase in the NADH/NAD+ ratio and 
thus an induction of mitochondrial dysfunction. However, there is not much 
literature that could clarify a role for this altered ratio in neuronal response to 
ethanol. Based on our analysis of these two genes, it is possible that 
disruption of this step in beta-oxidation could be significant in terms of FA and 
ethanol metabolism, but with this limited evidence, and ech-1.2 potentially 
being involved in both steps of beta-oxidation, the reason for its effect on 
modulating behavioral responses to ethanol could be multifold. For example, 
ratio of NADH/NAD+ is essential for metabolic pathways like glycolysis, 
gluconeogenesis, TCA cycle and FA synthesis. This ratio is also important for 
cell signaling and transcriptional regulation, since the enzymes involved in 
these processes require NAD+ and NADH for their functions. Therefore, 
altered ethanol responses observed in the ech-1.2 mutant could be due to 
disruption in any one or a combination of these pathways and enzymes. 
Measuring the NADH/NAD+ ratio in the ech-1.2 mutants could help us narrow 
down the possible mechanism of altered ethanol response. This ratio can be 
measured using commercially available fluorescence detection based 
NAD+/NADH assay kits. 
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3.9 Keto-acyl CoA Thiolases 
The two enzymes primarily involved in this pathway are KAT and ACAT. KAT 
catalyzes degradation of a broad range of 3-keto acyl CoA chain lengths to 
form an acyl CoA shortened by two carbons (acyl CoA(n-2)) and acetyl CoA. 
ACAT specifically catalyzes the last round of degradation in beta-oxidation, 
i.e., degradation of acetoacetyl CoA. In C. elegans, I studied two genes to 
look at the importance of this step in ethanol response. kat-1 is predicted to 
encode mitochondrial KAT and acaa-2 is an ortholog of the human ACAT. 
While kat-1 loss of function did not show difference in ethanol responses 
compared to WT, acaa-2 lf mutants showed decreased sensitivity to ethanol 
and in both mutants, the AFT is similar to WT worms. 
 
Loss of function of enzymes catalyzing the last step of mitochondrial beta-
oxidation that generates an acetyl CoA and an acyl CoA shortened by two 
carbons would be predicted to prevent release of acetyl CoA into downstream 
pathways like ketone body synthesis, the glyoxylate cycle, the TCA cycle and 
de novo FA synthesis. It would also lead to increase in 3-keto acyl CoA levels 
in the mitochondria. Lack of kat-1 functioning in beta-oxidation does not 
appear to affect neuronal response to ethanol and one possible reason for 
this is that kat-1, though predicted to be involved in mitochondrial beta-
oxidation (KEGG), is orthologous to ACAT1, a thiolase that is involved in 
breakdown of isoleucine and ketone bodies, and has not been implicated in 
mitochondrial beta-oxidation. A likely explanation for the decreased sensitivity 
seen in acaa-2 lf mutants is that acetyl CoA release into one or more of its 
downstream pathways is important for ethanol response. acaa-2 specifically 
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catalyzes the last round of beta-oxidation, and there is no further reentry of 
shortened acyl CoA into another round of oxidation and the only end-product 
of this reaction is acetyl CoA. Since acetyl CoA has several roles in various 
pathways of energy metabolism, it is difficult to predict which one of these 
could be important for ethanol response.  
 
Acetyl CoA is also utilized in cholinergic neurons for the synthesis of 
acetylcholine (Szutowicz et al., 2000). Several studies in humans and mouse 
models of alcohol-associated behavior have implicated neuronal nAChRs as 
potential targets of alcohol, though the exact mechanism and specific subunits 
of these receptors involved are not clear yet (Hendrickson et al., 2013; Tang & 
Liao, 2013). It would be interesting to see if the ethanol response phenotype 
seen in acaa-2 mutants is due to decrease in availability of acetyl CoA for 
acetylcholine synthesis, which could be connected to potential changes in 
ethanol interaction with nAChRs. A preliminary experiment that could help 
explore this direction would be to express acaa-2 in only the neurons 
expressing nAChRs (using pacr-2, promoter of acr-2 that is expressed 
specifically in these neurons), in acaa-2 deficient background. We could test 
ethanol responses of these worms to see if this rescues the phenotype. If 
acaa-2 lf is modifying ethanol sensitivity solely through decrease in 
acetylcholine synthesis, the expression of acaa-2 in the nAChR-expressing 
neurons should be able to restore WT initial sensitivity. But, if the initial 
sensitivity in these mutants is rescued to a certain extent (i.e., sensitivity is 
higher than acaa-2 lf but also significantly lower than WT), it suggests that 
acetylcholine synthesis is one of the mechanisms through which acaa-2 lf is 
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acting on sensitivity to ethanol and there are other mechanisms that 
contribute to this phenotype. Apart from acetylcholine synthesis, acetyl CoA is 
also involved in other metabolic pathways such as FA synthesis, which could 
be a mechanism through which the ethanol response phenotypes in the acaa-
2 mutants are being altered. 
 
3.10 Conclusion 
We tested various genes in the mitochondrial beta-oxidation pathway and saw 
that of the 34 genes we examined (including Dr. Alaimo’s data), loss of 
function of 13 genes showed a significant effect on ethanol response 
phenotype in C. elegans. Looking at the ethanol response phenotypes of lf 
mutants of all genes across enzyme families, it is clear that initial sensitivity to 
ethanol is affected in a higher number of mutants (in either direction), 
compared to AFT. Based on our experiments, we conclude that mitochondrial 
beta-oxidation of FA is essential for ethanol response behavior in C. elegans. 
However, considering the various roles of the substrate, intermediate 
metabolites and end product of beta-oxidation within and outside the 
mitochondria, it is difficult to hypothesize a single mechanism of the effect of 
these genes on neuronal response to ethanol. There are certain aspects of 
this pathway that seem to be particularly important, like FFA, acyl CoA and its 
derivatives, ratio of NADH/NAD+ and acetyl CoA. These components have 
been implicated in previous research on alcohol and its targets. It is likely that 
the effects of loss-of-function of the beta-oxidation enzymes are caused 
through more than one mechanism or compound that acts independently or 
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interacts with other pathways or compounds to influence ethanol response 
phenotypes.  
 
As discussed in this chapter, there is abundant scope for dissecting the role of 
individual genes identified through this project in the various downstream 
pathways of beta-oxidation and its intermediate products. This project lays the 
groundwork for further research on these candidate genes to test the possible 
and most likely mechanisms of their action on ethanol responses. 
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APPENDICES 
APPENDIX I 
 
1. DNA Isolation for PCR 
• Obtain a plate with full of adults, on the verge of starvation (more cells = more 
DNA) 
• Label a 1.5 mL eppendorf tube with strain name and “DNA” and date/initials 
• Use pure ddH2O (2 pumps of 850 mL = 1,700 mL) to wash plate 
• Decant and place in 1.5 mL Epp. tube 
• Centrifuge at highest speed for 30 seconds 
• Set pipetter to 1,000 PL 
• Decant all of the supernatant and discard 
• Add one mL of ddH2O 
• Spin in centrifuge again for one min 
• Remove all of the waste until there is only 0.1 mL left. Disturb pellet with a  
shake 
• Freeze in a -80qC freezer for 15 min (lysing step) (At this point the DNA can 
potentially stay in the freezer for a while, so this is an appropriate stopping 
point if you are too busy to finish.) 
• Set up the 95qC heat block and the 60qC water bath  
• Make a master mix of lysis buffer (refer to pg.121 for components of lysis 
buffer) and Proteinase K (12 PL Proteinase K/1,000 PL lysis buffer) 
• Add 1/3 of the solution in tubes (100 PL in tube = 33 X # of tubes + some for 
the PCR fairies) 
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o Example: 35μL Lysis Buffer X 5 DNA samples  = 175, so 175 PL is the total 
volume of Lysis Buffer 
o Add 180 PL of Lysis Buffer to the master mix tube 
o 175 Lysis Buffer X 12/1,000 = 2.1 PL Proteinase K (10 mg/mL) 
o Add the Pro K to the master mix tube and vortex to mix well. 
o Add 33 PL of master mix to each of your DNA samples. 
• Incubate at 60qC (the functional temperature of Proteinase K) Stick all tubes 
in a “floatie”, swirl, and let sit for about 90 min. 
• Incubate at 95qC to inactivate Proteinase K for 20 min. (use heat block) 
• When saving excel data, enter name of strain, conc., and time point 
• Store DNA tubes in -20qC incubator 
 
2. DNA Isolation for SWPCR 
• Add 5μL of 10 mg/mL Proteinase K to 95μL of lysis buffer in a 1.5mL 
eppendorf tube 
• Add 3μL of mix to 0.2mL PCR tubes 
• Pick 1-5 worms and place them into the solution 
• Place the tubes in the -80qC incubator for at least 20 minutes 
• Heat the tubes at 60qC for 60 minutes 
• Heat the tubes at 95qC for 15 minutes 
• Tap or spin the tubes to get the condensation to the bottom of the tube 
• The lysate can be used for PCR or can be stored in the -20qC incubator 
 
3. Standard PCR protocol 
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Note: All PCR is to be done on ice or in a cold storage box. Never leave out 
primers, enzymes, or DNA, as this will ruin it! 
 
• Dilute all primers to be used. Stock powdered primers are diluted in TE buffer 
unless they are to be used by the sequencing center. The sequencing center 
prefers all primers to be diluted in ddH20. The primers come with an 
information sheet detailing how much water or buffer is required to bring the 
primer up to 100 uM. Then make a personal dilution with 90 uL of ddH20 and 
10 uL of the stock primer in a labeled 1.5 mL eppendorf tube.  
• The next step is to create the PCR master mix. Label a 1.5 mL eppendorf 
tube with the pair of primers to be used, one tube per pair of primers. Always 
set up extra reaction mixtures because there is always loss via pipetting. Add 
the following per reaction: 
o ddH2O  6.7 uL 
o Reaction Buffer 1.0 uL 
o dNTP   0.2 uL 
o DreamTaq    0.1 uL 
o Forward Primer 0.5 uL 
o Reverse Primer 0.5 uL 
• Vortex the master mix to ensure contents are thoroughly mixed. Aliquot 9.0 uL 
of master mix to each of the PCR tubes. Then add 1.0 uL of DNA to each of 
the reaction tubes. If you desire to increase or decrease the amount of DNA 
used, be sure to alter the volume of water accordingly in the master mix. The 
total volume should always be 10 uL. 
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• If using the strips of tubes place all the caps on. If using a plate then affix the 
adhesive film securely on. Use the speedball to help securely fasten the film.  
• Put the strips or plate into the thermal cycler. 
• Select the “mapping program”: 
o 94q pause 
o 94q 2 minutes 
o 94q 15 seconds 
o 58q 45 seconds  35 cycles 
o 72q 1 minute 
o 72q 5 minutes 
• Store PCR products at -20qC. 
 
4. Single Worm PCR (SWPCR) protocol 
• Prepare a master mix in a 1.5 mL eppendorf tube (must be used immediately) 
o Add the following per reaction (taking into account the PCR fairies): 
ddH2O   13.4 μL 
Reaction Buffer 2.00 μL 
dNTP   0.40 μL 
DreamTaq  0.20 μL 
Forward Primer 1.00 μL 
Reverse Primer 1.00 μL 
• Aliquot 18μL of master mix to each PCR tube 
• Place in a thermocycler (times, temperatures and cycles between dotted lines 
may vary): 
o Select the “mapping program”: 
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94q pause 
94q 2 minutes 
94q 15 seconds 
58q 45 seconds  35 cycles 
72q 1 minute 
72q 5 minutes 
• Store PCR products at -20°C. 
 
5. GENEWIZ Guidelines for sample preparation for Sanger Sequencing 
(using Purified PCR Template) 
• Label your tubes on the side with your initials and sample number.  
• Dilute your sequencing primer (forward/reverse) to 5 µM (pmol/µl) using 
water. You will need 5 µl for each sequencing reaction.  
• For the amount of template needed for PreMixed sample, please refer to the 
table below. Prepare template in 10 µl for each sequencing reaction. Please 
make dilutions in water or Tris. For best results, do not use Tris-EDTA (TE) 
because EDTA will inhibit the sequencing reaction. 
• In the same tube, mix template (10 µl) and your primer (5 µl) 
according to the table below.   
Table 12. Concentration of DNA template and primer used for Purified PCR products in Sanger 
sequencing sample preparation 
DNA Type DNA/Product 
Length 
Template 
Concentration in 
10 µl 
Template Total 
Mass 
Your Primer 
Total Picomoles 
Premixed 
Volume*  
(Template + 
Your Primer) 
Purified 
PCR 
Products 
<500 bp ~1 ng / µl ~10 ng 25 pmol 15 µl 
500 - 1000 bp ~2 ng / µl ~20 ng 
1000 - 2000 bp ~4 ng / µl ~40 ng 
2000 - 4000 bp ~6 ng / µl ~60 ng 
> 4000 bp Treat as plasmid Treat as plasmid 
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6. RNAi Protocols 
a. Making RNAi Cultures from Frozen Stock 
1.) Turn on shaker and set at 37qC 
2.) Make LB/AMP solution 
▪ Take a bottle of LB (50 mL) 
▪ Add 50 ug/mL of ampicillin  
• 50 mL x 50 ug/mL = 2500 ug = 0.0025g  
▪ Vortex bottle for 30 seconds 
3.) Aliquot 5 mL of LB/AMP solution into 15 mL falcon tubes and label with gene 
name and date 
4.) Go to the -80 and take out frozen stock culture 
5.) Using the P2.5 with tip attached scrape frozen culture a few times to cover tip  
6.) Eject tip into falcon tube  
7.) Place tubes in the shaker at 37qC for 8-12 hours  
 
b. Freezing RNAi Cultures 
• Properly label (Formal name of gene, Gene name – if available, Library it 
came from, Date, Initals) 1.8 mL cryo tube vials  
• Note: you should have 1 tube for the -80qC freezer and 1 tube to be placed in 
the nitrogen tank 
• Pipette 300 uL of glycerol into the cryo tubes 
(Glycerol is very viscous so be sure to wait and make sure the correct amount 
is pipetted into your tip and expelled into the cyro tube) 
• Add 1.5 mL of inoculated RNAi culture into the cyro tube with glycerol, pipette 
up and down until mixed evenly 
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OR 
• Add 1.5 mL of inoculated RNAi culture into the cyro tube with glycerol.  
• Using an inoculation loop, flame loop 
• Immerse loop into inoculated RNAi culture 
• Then transfer loop, inoculating the culture in the cryo tube  
• Pipette inoculated culture and glycerol mixture up and down until 
evenly mixed 
• Place tubes into the -80qC freezer  
 
c. Preparing Ampicillin (+tetracycline) Plates for RNAi 
• 250 mL LB 
• 4.0g bacto-agar 
•  - Autoclave -  
• Place in 60C water for ~20minutes then add: 
• 250uL 50mg/mL Ampicillin 
• (167uL 15mg/mL tetracycline) 
• Pours ~25 medium plates 
 
d. Carbinacillin Plates for RNAi 
The following will make about 60 plates, which is equivalent to 0.75L.  
1. 0.722 L dH20 
2. 2.25 g NaCl 
3. 12.0 g Bacto-Agar 
4. 1.875 g Bacto-Peptone 
5. Swirl flask 
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6. Autoclave for 90 minutes under liquid cycle (usually takes 2 hours) 
7. Let cool for 30 minutes at room temperature 
8. 0.75 mL of MgSO4 (1M) 
9. 0.75 mL CaCl2 (1M) 
10. 0.75 mL Cholesterol (5 mg/mL) 
11. 18.75 mL KP04 (1M) 
12. 0.1875 mL Carbenicillin (100 mg/mL) 
13. 7.50 mL IPTG (0.1 M)  
 
Why we use these numbers 
For steps 8 – 11: 
We want a final concentration of 1 mM (0.001M) for each of these 
components.  
C1 = 1M 
V1 = X 
C2 = 0.001M 
V1 = 750 mL 
 
We have solutions that are at a 1 M concentration and we want to know how 
much of that solution do we need to add to give use a 0.001 M concentration 
of this solution in the total volume (750 mL) of our sample.  X = 0.75 mL 
 
For step 10: 
We want a final concentration of 25 ug/mL (0.025 mg/mL).  
C1 = 100 mg/mL 
 108 
V1 = X 
C2 = 0.025 mg/mL 
V2 = 750 mL 
 
We have the antibiotic that is at a concentration of 100 mg/mL. This is a 
standard concentration the lab makes. However, if you are ever using a 
different antibiotic, it is important to check the bottle or the manufactures 
website on how to suspend the chemical. I obtained 0.025 mg/mL final 
concentration of the antibiotic solution in the total volume (750 mL) of our 
sample. 
 
For Step 13:  
IPTG is our inducer for the vector/plasmid that is carrying the clone of our 
gene. The inducer allows for the initiation of the expression of the gene in the 
bacteria. The bacteria will produce a dsRNA and the worms eat the colonies 
on the plate allowing the dsRNA to be introduced to their system. dsRNA is 
obtained by allowing transcription in both directions of the plasmid rather than 
in one direction, which would just generate one strand that would not produce 
a knockdown of the gene. Once the dsRNA is in the system, the Dicer 
enzyme will breakdown the structure into smaller interfering RNA fragments 
called siRNAs (22 n.t.). The fragments are incorporated into a multicomponent 
nuclease, called RNA-induced silencing complex (RISC) and becomes 
activated with ATP. RISC then unwinds the siRNAs and uses them as a guide 
for substrate selection for the endogenous mRNA of the gene. Activated RISC 
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complexes can regulate gene expression at many levels. Such complexes act 
by promoting RNA degradation and translation inhibition. 
  
We want a final concentration of 1 mM (.001 M) for IPTG. In this case IPTG is 
recommended to be stored in a 0.1 M concentration. We have 0.1 M solution 
of IPTG but need to add X amount of this solution to end up with a final IPTG 
concentration of 0.001 M in 750 mL. X = 7.50 mL 
 
Making solutions: 
Carbenicillin: 
1.) Weigh out 100 mg 
2.) Add to tube 
3.) Bring the volume up to 1 mL  
4.) Vortex 
 
IPTG  
M.W. = 238.3 g 
1 Molar solution = 238.3 g / 1L 
0.1 Molar solution = 1.20 g / 50 mL 
1.) Weigh out 1.20 g 
2.) Add to tube 
3.) Bring volume up to 50 mL  
4.) Vortex 
5.) Aliquot out into smaller volumes  
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It is important to note, that if you are changing the amount of plates you need, 
you have to redo the calculations. For example, Steps 8-12 need to be 
subtracted from the total volume you what to give you the amount of water to 
add. Usually we will add some chemical and bring it up to volume to make 
some concentrated solution. This is the only case where we don’t account for 
dry contents such as steps 2-4, but it is important to get the concentrations 
right of the chemicals that matter.  
 
e. Plasmid DNA extraction using Invitrogen PureLink HQ Mini Plasmid 
Purification Kit 
Preparing Lysate 
• Prepare the Resuspension Solution with RNase A. Resuspend the lyophilized 
RNase A (12 mg) in 200 μl of Resuspension Solution, and then add the 
resuspended mixture to the remaining Resuspension Solution for a final 
concentration of 0.1 mg/ml RNase A. After mixing, Resuspension Solution 
should be stored at 4°C. 
• Prepare the Wash Buffer with ethanol. Add 64 ml of 96–100% ethanol to the 
entire volume of Wash Buffer (16 ml). 
• Check the Neutralization Buffer and Lysis Buffer before use for salt 
precipitate. If present, place each buffer in a 37°C water bath for 5 minutes 
until the salts redissolve and the solution clears. Do not shake the Lysis 
Buffer, as this can lead to foaming. 
 
Preparing Cell Lysate 
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• In a microcentrifuge tube, pellet 1–3 ml (1–2 × 109) of E. coli cells from 
overnight cultures by centrifugation in a tabletop centrifuge at 1,500 × g for 15 
minutes. 
• Completely resuspend the pellet in 240 μl of Resuspension Solution, prepared 
with RNase A as described above. 
• Add 240 μl of Lysis Buffer to the above solution. Mix gently by inverting the 
tube 4–8 times. 
• Incubate for 3–5 minutes at room temperature. Do not exceed 5 minutes. 
• Add 340 μl of Neutralization/Binding Buffer, and mix gently by inverting the 
tube 4–8 times. 
• Centrifuge for 10 minutes at maximum speed in a tabletop centrifuge to clarify 
the cell lysate. 
• Proceed to Binding DNA. 
 
Binding DNA 
• Place a PureLinkTM spin column inside a 2 ml collection tube. 
• Pipette or decant the supernatant from step 6, previous page, into the spin 
column. 
• Centrifuge the column at room temperature at 10,000–14,000 × g for 
• 1 minute. Discard the flowthrough, and place the column back in the tube. 
• If loading multiple samples on the same column (up to 1.5 × 1010 cells), 
repeat Steps 2–3 for each lysate. 
• Add 650 μl of Wash Buffer, prepared with ethanol as described on the 
previous page, to the column. 
• Centrifuge the column at room temperature at 10,000–14,000 × g for 
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• 1 minute. Discard the flowthrough from the collection tube, and place the 
column back in the tube. 
• Centrifuge the column at maximum speed for 1–3 minutes to remove the 
residual wash buffer. 
• Proceed to Eluting DNA. 
 
Eluting DNA 
• Place the spin column in a clean 1.7 ml elution tube. Add Elution Buffer or 
sterile, distilled water as specified below 
• · Add 50 μl of Elution Buffer or water to the center of the column if the 
expected DNA yield is <30 μg. 
• · Add 100 μl of Elution Buffer or water to the center of the column if the 
expected DNA yield is >30 μg. 
• Incubate the column at room temperature for 1 minute, then centrifuge at 
maximum speed for 1 minute. 
• The elution tube contains your purified DNA. Remove and discard the column. 
 
f. GENEWIZ– Guidelines for sample preparation for Sanger Sequencing 
(using Plasmid DNA Template) 
• Label your tubes on the side with your initials and sample number.  
• Dilute your sequencing primer (forward/reverse) to 5 µM (pmol/µl) using 
water. You will need 5 µl for each sequencing reaction.  
• For the amount of template needed for PreMixed sample, please refer to the 
table below. Prepare template in 10 µl for each sequencing reaction. Please 
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make dilutions in water or Tris. For best results, do not use Tris-EDTA (TE) 
because EDTA will inhibit the sequencing reaction. 
• In the same tube, mix template (10 µl) and your primer (5 µl) 
according to the table below.   
Table 13. Concentration of DNA template and primer used for Plasmid DNA template in Sanger 
sequencing sample preparation 
DNA Type DNA Length 
(include vector) 
Template 
Concentration in 
10 µl 
Template Total 
Mass 
Your Primer 
Total Picomoles 
Premixed 
Volume*  
(Template + 
Your Primer) 
Plasmids <6 kb ~50 ng / µl ~500 ng 25 pmol 15 µl 
6 - 10 kb ~80 ng / µl ~800 ng 
> 10 kb ~100 ng / µl ~1000 ng 
 
 
7. Ethanol Assay with Copper Rings 
• Dry NGM plates with the lids removed in the 37°C incubator for two hours.  
• Remove the plates and allow them to equilibrate to room temperature for 
about 15 minutes, evaporation will continue to occur. 
• Weigh each plate and record the weight on the side of the plate. 
• Heat the copper rings and melt them into the surface of the agar, be careful to 
not touch the hot forceps to the agar. Tap the rings with the forceps to make 
sure the ring is melted completely into the agar. If the ring is not completely in 
the agar then the worms will be able to crawl out. Four rings maximum per 
plate. 
• Using the available ethanol table select the correct concentration and the 
weight of your plate and add that much ethanol to your assay plate. Be sure to 
save an equal number of plates with rings and no ethanol for starvation 
plates. 
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• Record the weights of your plates and the amount of ethanol added in your 
laboratory notebook. 
• Allow the ethanol to equilibrate for approximately 2 hours 
• After the ethanol has equilibrated move your animals into their rings and 
remove all food by gently scraping it off with your pick. Be sure to flame in 
between rings to avoid transferring worms of one strain into a ring of worms of 
a different strain. 
• Allow the worms to starve for 30 minutes. This minimizes the food left on their 
bodies.  
• Transfer the worms from the starvation plates onto the assay plates. This 
transfer must be as speedy as possible to ensure accurate data, aim for less 
than 2 minutes per plate. Parafilm the plates after the worms have all been 
transferred and start a timer.  
• Depending on the type of assay you may need to observe your assay plates 
or you may need to track your worms using the computer and camera rig.  
 
8. Computer Tracking and Analyzing Movies 
a. Taking movies: 
• Open Image-Pro Plus 6.0 
• Turn on the camera and the light source 
• Click on “Acquire” at the tope of the Image Pro window 
• Select “Video/Digital Capture” 
• The window that pops up on the right half of the screen (labeled “QImaging 
Digital Camera”) will have information regarding different camera settings. 
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The settings already in place should be the ones most commonly used unless 
Jill or Andrew says otherwise. 
• Click on “Preview” at the top left corner of the QImaging Digital Camera 
window. 
• Place ringed plate on the light source at the base of the microscope using the 
“Live Preview” window to put all rings in the camera’s field of view. Also use 
the preview window to adjust the lab light source to the proper brightness to 
take a clear image. 
• Click on “Snap” at the top left corner of the QImaging Digital Camera window, 
and save the image (as a .seq file) to designated folder. 
 
b. Analyzing movies: 
• Open Image-Pro Plus 6.0 
• Click on “File” and select “Open” to load video saved in a designated file 
• Click on “Macro” heading at the top of the Image-Pro window and select  
• “flatten_magnify_add_ring” 
• Drag the white ring that appears over to the ring of worms to analyze, and 
adjust the white ring to fit the shape of the copper ring 
• Click on “Measure” heading at the top of the Image-Pro window and select 
“Track Objects” 
• Click on the track objects automatically icon (yellow lightning bolt icon on top 
right side of the “Tracking Data Table” window 
• Three smaller windows will pop up. On “Count/Size” window click on “Select 
Ranges” and adjust vertical line to adjust brightness in order to outline each 
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worm, but without making the background appear too bright. Close window 
when properly adjusted. 
• Use “Sequencer Toolbar” to select the movie frame that captures the most 
number of worms in the selected ring. 
• Click on “Count” in the Count/Size window, and then click on “Continue” in the 
Tracking window. 
• Two sets of boxes with questions will pop up. For the first box that pops up 
click on “Yes,” and for the second window that pops up click on “No.” 
• A list of tracks with speeds will appear in the Tracking Data Table window. 
Click on tracks making sure they accurately records paths of worms, deleting 
tracks that are recording miscellaneous objects (using blue X to delete 
selected track). 
• Once true worm tracks are remaining, open up an Excel file, and click on the 
green Excel icon at the top right of the Tracking Data Table window to import 
list of tracks and speeds to Excel. Because mean speed is the information of 
interest, on a separate worksheet on the Excel file, make a table for the mean 
speeds for each strain of worms for each time point recorded.  
• ****Make sure to make a new worksheet before importing the tables for each 
ring. Otherwise, the table will import over the previously imported table. 
 
9. Recipes 
S Basal (400 mL) 
• 8 mL 5 M NaCl 
• 20 mL 1 M KPO4 (pH 6) 
• 372 mL dH2O 
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- Post Autoclave - 
• 400 μL 5 mg/mL cholesterol 
 
 M9 (1 Liter) 
• 6 g Na2HPO4  
• 3 g KH2PO4 
• 5 g NaCl 
• 1 mL of 1M MgSO4  
- Autoclave - 
 
Freezing Solution (1 Liter) 
• 18 mL 5 M NaCl  (Must be heated and swirled vigorously) 
• 50 mL 1 M KPO4 (pH 6) 
• 300 mL DMSO 
• 632 mL dH2O S Buffer (1L) 
• 129 mL 0.05 M K2HPO4  
• 871 mL 0.05 M KH2PO4 
• 5.85 g NaCl 
- Autoclave - 
 
4X Lysis Buffer (100 mL) 
• 1.491 g KCl 
• 0.4856 g Tris 
• 0.2033 g MgCl2 
• 0.04 g Gelatin 
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• 1.8 mL NP4O 
• 1.8 mL Tween-20 
- Autoclave (Filter)- 
 
1L KPO4 (pH 6.0) in H2O 
• 110.26g KH2PO4 
• 33.064g K2HPO4  
 
2.5 mM dNTP 
• 2.5 μL of each of the 4 dNTPs 
• 90 μL ddH20 
 
LB 
• 1 Tablet per 50 mL H2O 
- Autoclave (same day) -  
 
Cholesterol 
• 5 mg/mL in 95% EtOH 
- Filter Sterilize - 
 
Proteinase K 
• 10 mg/mL in H2O 
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APPENDIX II 
 
Table 14. Primers for PCR of mutant C. elegans strains obtained from Caenorhabditis Genetics Center 
website. 
Strain Genotype Forward Primer(s) Reverse Primer(s) 
Annealing 
temperature 
(°C) 
VC2240 acs-4 (ok2872) 
CTGTTTCAGGCAAATTGGGT 
(out) 
TTCCTGTGCTCAAGTCGTTG 
(out) 
69.6 
ATGTTTGGGAACTCGACAGC 
(in) 
ATCCTTGAACAACAGGGCAG 
(in) 
69.6 
RB2015 acs-5 (ok2668) 
AACAACACGTTGCTGGAGTG 
(out) 
CCACCCATGGCCTAACTCTA 
(out) 
Not used 
TCTAATCGAGTTGGATTCACG 
(in) 
TGCAATTACAGGGTCAACCA 
(in) 
64 
RB1377 acs-17 (ok1562) 
GGTCGATTCTTCGATTTCCA 
(out) 
TGGGGAGCATAGGTTTTTCA 
(out) 
Not used 
CCTAAAACATATGGCCACCG 
(in) 
TGAACGCACGGTATGTTTGT 
(in) 
64 
VC1087 acdh-1 (ok1514) 
GTCACCTCAAACCAAGGGAA 
(out) 
GGTGGGATGTACGGTAGGAG 
(out) 
62 
CTTCAGCAATATTCCAGCCC 
(in) 
AACGGAAGGCGAATCAATTA 
(in) 
64 
RB2101 hacd-1 (ok2776) 
AAGCTCAATGGCTTTTTCCA 
(out) 
CGTTTTTCTGCCAAGCTTTC 
(out) 
64 
CAGAAATTTTCCCCCACAAA 
(in) 
CAGCGACCAATTTGTCCATAA 
(in) 
64 
RB1606 acaa-2 (ok1978) 
TTCGTGAAGCATATTGCGAG 
(out) 
GCCCCTTGATAGTGATTCCA 
(out) 
Not used 
CCATTTCCTATTTTCCCCGT (in) GTATTGTGCGCCCAACTTCT (in) 
64 
RB2566 T02G5.7 (ok3574) 
CAGTCTATCGCAATGTCGGA 
(out) 
GGAGTTGACGATTCGGAGAC 
(out) 
63.5 
CCGAGGATCTTTCGCTAACTT 
(in) TTTCCGAAAACGCTCACTG (in) 
Not used 
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Table 15. Primers for PCR of mutant C. elegans strains designed on NCBI Primer-BLAST 
 
 
 
 
 
 
 
 
 
 
 
Strain Genotype Forward Primer(s) Reverse Primer(s) Annealing 
temperature 
(°C) 
VC40812  acs-3 
(gk826522) 
TCCTTAGCTCACATCTATGAGC GTTAAAAAACGTCTGCAGTTTCC 63.5 
RB2015  acs-5 
(ok2668) 
CCCAGATAGTGTCACGACCG 
(within deletion) 
GAGCAGCTCACTCACTGGAC 
(within deletion) 
67.2 
RB2147  acs-13 
(ok2861) 
TGAACAAATGATTGAGCGACA 
(out) 
ACCGATGAGCTCAAAACGAC 
(out) 
63.5 
CGACACATTCCGTTTGACCG (in) GGCTCACATGCTCGAGAGAG 
(in) 
Not used 
VC20634 acs-22 
(gk364606) 
TGTCGTCAAGGATGGAACGG AAGTGAAATGAGCCGAGAGGG 69.6 
VC20616 cpt-3 
(gk356297) 
GAAACAAACCCGAAGACAACTG AGAATGATAAGAGGTGATGTGA
ACC 
63.5 
VC40798  cpt-4 
(gk818803) 
TACTCTTCCAGGAACGGGCT 
 
TCGACATTAGGCAATTTTGGCA 
 
66 
VC40360  cpt-6 
(gk594576) 
ACATGGCTTCTTTGGGTTGTC 
 
CACCACAACATCACTCACGTTC 
 
63.5 
VC20502  acdh-2 
(gk143151) 
TCCTGCACGCATTCCAAGAT (out) CCTACAAGGCGACCTACACC 
(out) 
69.6 
CCTGAAAGTTTTACAC (in) TTCTCAACGGATCAAAACGG 
(in_WT nucleotide at SNP) 
TTCTCAACGGATCAAAACGA 
(in_mutant nucleotide at SNP) 
60 
VC40973 acdh-5 
(gk907299) 
GAACTTGGAAGAATAACTTCCAGG GTGTGTGTGCACAGCTGATA 63.5 
VC40929  acdh-6 
(gk886629) 
TCAGGCACAACACAAAAGTCG CTCACCAAATTGTGCAAGAGCA 63.5 
VC40288  acdh-7 
(gk556025) 
CGGGAAAGCATATTTAACCTGC 
 
TCACTCTTCCAGGTTGACG 63.5 
VC40665  acdh-11 
(gk753061) 
CGTTGAGACCAGGTACCGTAT 
 
GTCATAGCCATCGGACAGGA 66 
VC41029 F54D5.7 
(gk936057) 
GTGGAACGAGTCGATTCGGGA ACTTTTCCCTCATCTTTCAGGCG 63.5 
VC40235 ech-1.2 
(gk527451) 
TTTGGGTACCTCCAGCTCCT 
 
AGATGTTGCCGTGGTGAAGA 
 
63.5 
QC119 ech-7 (et6) TGTGCTTACATCGGCCCTAC CATCTAGGCAGACAGGCAGG 66 
VC2462 T02G5.4 
(ok3160) 
GCATTCCAATTTTTCCAGGTCTGT GCTCCTCCATGTGGGTTCAC 
 
63.5 
VS24 kat-1 
(tm1037) 
GTCTCTCATTCATCTCGATCCG 
(out) 
AACTGCTTCCTGTGAGGCAA 
(out) 
63.5 
  AGGAGGCGAGTGTGTTCTTT 
(within deletion) 
ATAAGCATCGGTCAGTCCGTC 
(within deletion) 
63.5 
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Table 16. Restriction enzymes and digest conditions used for snipSNP genotype detection 
Strain Genotype SNP (WT/Variant) Restriction site 
sequence 
Restriction 
enzyme 
Restriction Digest Conditions 
Incubation Inactivation 
VC20634 acs-22 
(gk364606) 
C/T 5′…T▼CGA…3′ 
 
3′…AGC▲T…5′ 
 
TaqI 65 °C (4hr) 80 °C (20 
minutes) 
VC40812  acs-3 
(gk826522) 
T/A 5′…C▼TNAG…3′ 
 
3′…GANT▲C…5′ 
 
DdeI 37 °C (4hr) 65 °C (20 
minutes) 
VC20616 cpt-3 
(gk356297) 
C/T 5′…ACN▼GT…3′ 
 
3′…TG▲NCA…5′ 
 
Hpy188I 37 °C (4hr) 65 °C (20 
minutes) 
VC40360  cpt-6 
(gk594576) 
C/T 5′…GG▼CC…3′ 
 
3′…CC▲GG…5′ 
 
HaeIII 37 °C (4hr) 80 °C (20 
minutes) 
VC41029 F54D5.7 
(gk936057) 
G/A 5′…C▼CCAGC…3′ 
3′…GGGTC▲G…5
′ 
BseYI 37 °C (4hr) 80 °C (20 
minutes) 
VC40798  cpt-4 
(gk818803) 
G/C 5′…C▼AATTG…3′ 
3′…GTTAA▲C…5′ 
MfeI 37 °C (4hr) No 
inactivation 
 
 
Table 17. RNAi plasmid DNA concentrations quantified using NanoDrop 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gene name Gene name (in RNAi library) DNA Concentration 
(ng/μL) 
acs-16 F47G6.2 74.8 
W03F9.4 W03F9.4 28.9 
acdh-4 T10E9.9 91 
acdh-8 K05F1.3 24.4 
acdh-10 T08G2.3 22.5 
acdh-12 E04F6.5 49.9 
ech-1.1 C29F3.1 34.9 
B0303.3 B0303.3 32.3 
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Table 18. 100% Ethanol volumes for various plate weights for specific final concentrations of ethanol (in 
mM). 
Plate weight 
(g) 
Agar 
Vol 
(ml) 
50 100 150 200 250 300 350 400 450 500 
17.9 10.0 30.1 60.2 90.3 120.4 145.5 180.7 206.8 232.9 262.0 291.1 
17.8 9.9 29.8 59.6 89.4 119.3 144.1 178.9 204.7 230.6 259.4 288.2 
17.7 9.8 29.5 59.0 88.6 118.1 142.7 177.1 202.7 228.3 256.8 285.4 
17.6 9.7 29.2 58.4 87.7 116.9 141.3 175.3 200.7 226.0 254.3 282.5 
17.5 9.6 28.9 57.9 86.8 115.7 139.8 173.6 198.6 223.7 251.7 279.7 
17.4 9.5 28.6 57.3 85.9 114.5 138.4 171.8 196.6 221.4 249.1 276.8 
17.3 9.4 28.3 56.7 85.0 113.4 137.0 170.0 194.6 219.2 246.5 273.9 
17.2 9.3 28.0 56.1 84.1 112.2 135.5 168.3 192.6 216.9 244.0 271.1 
17.1 9.2 27.7 55.5 83.2 111.0 134.1 166.5 190.5 214.6 241.4 268.2 
17.0 9.2 27.5 54.9 82.4 109.8 132.7 164.7 188.5 212.3 238.8 265.4 
16.9 9.1 27.2 54.3 81.5 108.6 131.3 162.9 186.5 210.0 236.3 262.5 
16.8 9.0 26.9 53.7 80.6 107.4 129.8 161.2 184.5 207.7 233.7 259.7 
16.7 8.9 26.6 53.1 79.7 106.3 128.4 159.4 182.4 205.4 231.1 256.8 
16.6 8.8 26.3 52.5 78.8 105.1 127.0 157.6 180.4 203.2 228.6 254.0 
16.5 8.7 26.0 52.0 77.9 103.9 125.5 155.9 178.4 200.9 226.0 251.1 
16.4 8.6 25.7 51.4 77.0 102.7 124.1 154.1 176.3 198.6 223.4 248.2 
16.3 8.5 25.4 50.8 76.2 101.5 122.7 152.3 174.3 196.3 220.8 245.4 
16.2 8.4 25.1 50.2 75.3 100.4 121.3 150.5 172.3 194.0 218.3 242.5 
16.1 8.3 24.8 49.6 74.4 99.2 119.8 148.8 170.3 191.7 215.7 239.7 
16.0 8.2 24.5 49.0 73.5 98.0 118.4 147.0 168.2 189.5 213.1 236.8 
15.9 8.1 24.2 48.4 72.6 96.8 117.0 145.2 166.2 187.2 210.6 234.0 
15.8 8.0 23.9 47.8 71.7 95.6 115.6 143.4 164.2 184.9 208.0 231.1 
15.7 7.9 23.6 47.2 70.8 94.5 114.1 141.7 162.1 182.6 205.4 228.3 
15.6 7.8 23.3 46.6 70.0 93.3 112.7 139.9 160.1 180.3 202.9 225.4 
15.5 7.7 23.0 46.0 69.1 92.1 111.3 138.1 158.1 178.0 200.3 222.5 
15.4 7.6 22.7 45.5 68.2 90.9 109.8 136.4 156.1 175.8 197.7 219.7 
15.3 7.5 22.4 44.9 67.3 89.7 108.4 134.6 154.0 173.5 195.2 216.8 
15.2 7.4 22.1 44.3 66.4 88.5 107.0 132.8 152.0 171.2 192.6 214.0 
15.1 7.3 21.8 43.7 65.5 87.4 105.6 131.0 150.0 168.9 190.0 211.1 
15.0 7.2 21.5 43.1 64.6 86.2 104.1 129.3 147.9 166.6 187.4 208.3 
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Table 19. Average basal speeds of 2x backcrossed mutant strains at 0mM ethanol concentration at 
two different time points (10 minutes and 30 minutes after being transferred to the assay plate)  
 
Table 20. Average basal speeds of 6x backcrossed mutant strains at 0mM ethanol concentration at 
two different time points (10 minutes and 30 minutes after being transferred to the assay plate) 
        
Genotype Number of assays Average speed (μm/s) 
at 0mM (10 minutes) 
Average speed (μm/s) 
at 0mM (30 minutes) 
acs-3(gk826522) 6 177.14 161.03 
acs-4(ok2872) 5 178.28 171.06 
acs-5(ok2668) 6 138.99 119.65 
acs-13(ok2861) 6 183.71 173.99 
acs-17(ok1562) 6 222.56 213.14 
acs-22(gk364606) 6 163.51 166.90 
cpt-3(gk356297) 8 164.42 173.25 
cpt-4(gk818803) 8 197.20 190.09 
cpt-6(gk594576) 6 177.41 187.07 
acdh-1(ok1514) 5 144.56 155.14 
acdh-2(gk143151) 6 168.21 161.27 
acdh-5(gk907299) 6 203.16 198.63 
acdh-6(gk886629) 6 192.58 195.61 
acdh-7(gk556025) 5 165.92 173.96 
acdh-11(gk753061) 6 196.31 192.36 
F54D5.7(gk936057) 6 156.83 177.66 
ech-1.2(gk527451) 8 189.90 188.60 
hacd-1(ok2776) 6 189.65 187.49 
T02G5.4(ok3160) 5 169.56 165.47 
T02G5.7(ok3574) 6 170.32 173.06 
acaa-2(ok1978) 6 211.28 214.60 
Genotype Number of assays Average speed (μm/s) 
at 0mM (10 minutes) 
Average speed (μm/s) 
at 0mM (30 minutes) 
acs-3(gk826522) 6 108.53 110.71 
acs-4(ok2872) 6 130.99 140.57 
acs-5(ok2668) 6 124.63 117.14 
acs-13(ok2861) 6 200.30 187.15 
acs-22(gk364606) 6 178.62 165.34 
cpt-3(gk356297) 6 203.25 210.77 
cpt-4(gk818803) 6 188.81 183.07 
acdh-1(ok1514) 6 139.50 142.72 
acdh-2(gk143151) 6 173.58 179.21 
acdh-7(gk556025) 6 169.38 177.73 
ech-1.2(gk527451) 6 67.90 58.06 
T02G5.4(ok3160) 6 198.62 194.25 
acaa-2(ok1978) 6 220.67 219.10 
ech-7(et6) 6 188.48 195.41 
kat-1(tm1037) 6 173.86 171.21 
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Table 21. Average basal speeds of RNAi-mediated knockdown worms at 0mM ethanol 
concentration at two different time points (10 minutes and 30 minutes after being transferred to the 
assay plate) 
 
 
Genotype Number of assays Average speed (μm/s) 
at 0mM (10 minutes) 
Average speed (μm/s) 
at 0mM (30 minutes) 
W03F9.4 (RNAi) 8 215.73 209.00 
acdh-4 (RNAi) 8 212.82 200.93 
acdh-8 (RNAi) 8 208.47 193.41 
acdh-10 (RNAi) 8 205.54 196.66 
acdh-12 (RNAi) 8 209.97 195.93 
ech-1.1 (RNAi) 8 220.20 209.62 
B0303.3 (RNAi) 8 216.41 198.93 
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APPENDIX III 
 
1. Graphs of ethanol response phenotypes of 2x backcrossed mutants of 
candidate genes in the mitochondrial beta-oxidation pathway 
 
 
 
Figure 11. Ethanol sensitivity and acute functional tolerance (AFT) of 2x 
backcrossed acs-3 lf mutant. At 400mM exogenous ethanol these mutants 
displayed increased initial sensitivity and reduced development of AFT 
relative to N2 (n = 4)  
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Figure 12. Ethanol sensitivity and acute functional tolerance (AFT) of 2x 
backcrossed acs-4 lf mutant. At 400mM exogenous ethanol these mutants 
displayed increased initial sensitivity but no significant difference in 
development of AFT relative to N2 (n = 6)  
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Figure 13. Ethanol sensitivity and acute functional tolerance (AFT) of 2x 
backcrossed acs-5 lf mutant. At 400mM exogenous ethanol these mutants 
displayed increased initial sensitivity and no significant development of AFT 
relative to N2 (n = 6).  
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Figure 14. Ethanol sensitivity and acute functional tolerance (AFT) of 2x 
backcrossed acs-13 lf mutant. At 400mM exogenous ethanol these mutants 
displayed decreased initial sensitivity and no significant difference in the 
development of AFT relative to N2 (n = 4)  
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Figure 15. Ethanol sensitivity and acute functional tolerance (AFT) of 2x 
backcrossed acs-17 lf mutant. At 400mM exogenous ethanol these mutants 
did not differ significantly from N2 in terms of initial sensitivity and AFT 
development (n = 6)  
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Figure 16. Ethanol sensitivity and acute functional tolerance (AFT) of 2x 
backcrossed acs-22 lf mutant. At 400mM exogenous ethanol these mutants 
displayed reduced development of AFT, but not significantly different initial 
sensitivity relative to N2 (n = 6)  
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Figure 17. Ethanol sensitivity and acute functional tolerance (AFT) of 2x 
backcrossed cpt-3 lf mutant. At 400mM exogenous ethanol these mutants did 
not differ significantly from N2 in terms of initial sensitivity and AFT 
development (n = 8) 
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Figure 18. Ethanol sensitivity and acute functional tolerance (AFT) of 2x 
backcrossed cpt-4 lf mutant. At 400mM exogenous ethanol these mutants did 
not differ significantly from N2 in terms of initial sensitivity and AFT 
development (n = 8) 
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Figure 19. Ethanol sensitivity and acute functional tolerance (AFT) of 2x 
backcrossed cpt-6 lf mutant. At 400mM exogenous ethanol these mutants did 
not differ significantly from N2 in terms of initial sensitivity and AFT 
development (n = 4) 
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Figure 20. Ethanol sensitivity and acute functional tolerance (AFT) of 2x 
backcrossed ech-1.2 lf mutant. At 400mM exogenous ethanol these mutants 
did not differ significantly from N2 in terms of initial sensitivity but showed 
reduced development of AFT compared to N2 (n = 8) 
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Figure 21. Ethanol sensitivity and acute functional tolerance (AFT) of 2x 
backcrossed F54D5.7 lf mutant. At 400mM exogenous ethanol these mutants 
did not differ significantly from N2 in terms of initial sensitivity and AFT 
development (n = 4) 
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Figure 22. Ethanol sensitivity and acute functional tolerance (AFT) of 2x 
backcrossed acdh-1 lf mutant. At 400mM exogenous ethanol these mutants 
had significantly increased sensitivity but did not differ significantly from N2 in 
terms of their AFT development (n = 5) 
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Figure 23. Ethanol sensitivity and acute functional tolerance (AFT) of 2x 
backcrossed acdh-2 lf mutant. At 400mM exogenous ethanol these mutants 
did not differ significantly from N2 in terms of initial sensitivity but displayed 
significantly reduced AFT development (n = 6) 
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Figure 24. Ethanol sensitivity and acute functional tolerance (AFT) of 2x 
backcrossed acdh-5 lf mutant. At 400mM exogenous ethanol these mutants 
did not differ significantly from N2 in terms of initial sensitivity and AFT 
development (n = 5) 
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Figure 25. Ethanol sensitivity and acute functional tolerance (AFT) of 2x 
backcrossed acdh-6 lf mutant. At 400mM exogenous ethanol these mutants 
did not differ significantly from N2 in terms of initial sensitivity and AFT 
development (n = 5) 
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Figure 26. Ethanol sensitivity and acute functional tolerance (AFT) of 2x 
backcrossed acdh-7 lf mutant. At 400mM exogenous ethanol these mutants 
displayed significantly decreased initial sensitivity and had reduced 
development of AFT relative to N2 (n = 5) 
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Figure 27. Ethanol sensitivity and acute functional tolerance (AFT) of 2x 
backcrossed acdh-11 lf mutant. At 400mM exogenous ethanol these mutants 
did not differ significantly from N2 in terms of initial sensitivity and AFT 
development (n = 5) 
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Figure 28. Ethanol sensitivity and acute functional tolerance (AFT) of 2x 
backcrossed hacd-1 lf mutant. At 400mM exogenous ethanol these mutants 
did not differ significantly from N2 in terms of initial sensitivity and AFT 
development (n = 6) 
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Figure 29. Ethanol sensitivity and acute functional tolerance (AFT) of 2x 
backcrossed T02G5.4 lf mutant. At 400mM exogenous ethanol these mutants 
showed significantly decreased initial sensitivity but they did not differ from N2 
in terms of AFT development (n = 5) 
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Figure 30. Ethanol sensitivity and acute functional tolerance (AFT) of 2x 
backcrossed T02G5.7 lf mutant. At 400mM exogenous ethanol these mutants 
did not differ significantly from N2 in terms of initial sensitivity and AFT 
development (n = 6) 
 
n=6 
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Figure 31. Ethanol sensitivity and acute functional tolerance (AFT) of 2x 
backcrossed acaa-2 lf mutant. At 400mM exogenous ethanol these mutants 
showed a significantly decreased initial sensitivity than N2 but did not differ 
significantly from N2 in terms of AFT development (n = 6) 
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2. Graphs of ethanol response phenotypes of 6x backcrossed mutants of 
candidate genes in the mitochondrial beta-oxidation pathway 
 
 
 
 
 
Figure 32. Ethanol sensitivity and acute functional tolerance (AFT) of 6x 
backcrossed acs-5 lf mutant. At 400mM exogenous ethanol these mutants 
displayed increased initial sensitivity and reduced development of AFT 
relative to N2 (n = 6).  
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Figure 33. Ethanol sensitivity and acute functional tolerance (AFT) of 6x 
backcrossed acs-13 lf mutant. At 400mM exogenous ethanol these mutants 
displayed decreased initial sensitivity, but no significant difference in the 
development of AFT relative to N2 (n = 6).  
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Figure 34. Ethanol sensitivity and acute functional tolerance (AFT) of 6x 
backcrossed acs-22 lf mutant. At 400mM exogenous ethanol these mutants 
did not show any significant difference in terms of initial sensitivity or AFT 
relative to N2 (n = 6).  
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Figure 35. Ethanol sensitivity and acute functional tolerance (AFT) of 6x 
backcrossed cpt-3 lf mutant. At 400mM exogenous ethanol these mutants did 
not show any significant difference in terms of initial sensitivity or AFT relative 
to N2 (n = 6).  
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Figure 36. Ethanol sensitivity and acute functional tolerance (AFT) of 6x 
backcrossed acdh-1 lf mutant. At 400mM exogenous ethanol these mutants 
displayed significantly decreased sensitivity compared to N2, but did not show 
any significant difference in terms of AFT development relative to N2 (n = 6).  
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Figure 37. Ethanol sensitivity and acute functional tolerance (AFT) of 6x 
backcrossed acdh-2 lf mutant. At 400mM exogenous ethanol these mutants 
displayed significantly decreased sensitivity compared to N2, but did not show 
any significant difference in terms of AFT development relative to N2 (n = 6).  
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Figure 38. Ethanol sensitivity and acute functional tolerance (AFT) of 6x 
backcrossed acdh-7 lf mutant. At 400mM exogenous ethanol these mutants 
did not show any significant difference in terms of initial sensitivity but 
displayed significantly reduced AFT development relative to N2 (n = 6).  
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Figure 39. Ethanol sensitivity and acute functional tolerance (AFT) of 10x 
backcrossed ech-7 lf mutant (without paqr-2 deletion). At 400mM exogenous 
ethanol these mutants did not show any significant difference in terms of initial 
sensitivity but displayed significantly reduced AFT development relative to N2 
(n = 6).  
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Figure 40. Ethanol sensitivity and acute functional tolerance (AFT) of 6x 
backcrossed T02G5.4 lf mutant. At 400mM exogenous ethanol these mutants 
did not show any significant difference in terms of initial sensitivity or AFT 
development relative to N2 (n = 6).  
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Figure 41. Ethanol sensitivity and acute functional tolerance (AFT) of 6x 
backcrossed acaa-2 lf mutant. At 400mM exogenous ethanol these mutants 
had significantly decreased initial sensitivity compared to N2 but did not show 
any significant difference in terms of AFT development relative to N2 (n = 6).  
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Figure 42. Ethanol sensitivity and acute functional tolerance (AFT) of 6x 
backcrossed kat-1 lf mutant. At 400mM exogenous ethanol these mutants did 
not show any significant difference in terms of initial sensitivity or AFT 
development relative to N2 (n = 6).  
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3. Graphs of ethanol response phenotypes of RNAi-mediated knockdown of 
candidate genes in the mitochondrial beta-oxidation pathway 
 
 
Figure 43. Ethanol sensitivity and acute functional tolerance (AFT) of 
W03F9.4 RNAi knockdown of C. elegans. At 400mM exogenous ethanol 
these worms did not show any significant difference in terms of initial 
sensitivity or AFT development relative to L4440 (n = 8).  
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Figure 44. Ethanol sensitivity and acute functional tolerance (AFT) of acdh-4 
RNAi knockdown of C. elegans. At 400mM exogenous ethanol these worms 
did not show any significant difference in terms of initial sensitivity or AFT 
development relative to L4440 (n = 8).  
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Figure 45. Ethanol sensitivity and acute functional tolerance (AFT) of acdh-8 
RNAi knockdown of C. elegans. At 400mM exogenous ethanol these worms 
did not show any significant difference in terms of initial sensitivity or AFT 
development relative to L4440 (n = 8).  
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Figure 46. Ethanol sensitivity and acute functional tolerance (AFT) of acdh-10 
RNAi knockdown of C. elegans. At 400mM exogenous ethanol these worms 
showed a significantly decreased sensitivity to ethanol and reduced AFT 
development compared to L4440 (n = 8).  
 
 
 
 161 
 
Figure 47. Ethanol sensitivity and acute functional tolerance (AFT) of acdh-12 
RNAi knockdown of C. elegans. At 400mM exogenous ethanol these worms 
showed a significantly decreased sensitivity to ethanol but no significant 
difference in development of AFT relative to L4440 (n = 8).  
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Figure 48. Ethanol sensitivity and acute functional tolerance (AFT) of ech-1.1 
RNAi knockdown of C. elegans. At 400mM exogenous ethanol these worms 
did not show any significant difference in terms of initial sensitivity or AFT 
development relative to L4440 (n = 8).  
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Figure 49. Ethanol sensitivity and acute functional tolerance (AFT) of B0303.3 
RNAi knockdown of C. elegans. At 400mM exogenous ethanol these worms 
did not show any significant difference in terms of initial sensitivity or AFT 
development relative to L4440 (n = 8). 
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